LOAN AND SECURITY AGREEMENT
Exhibit 10.2
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”)
dated as of May 27, 2010 (the “Effective Date”)
among MIDCAP FINANCIAL, LLC, a Delaware limited
liability company, with an office located at 0000
Xxx Xxxxxxxxxx Xxxx, Xxxxx 000, Xxxxxxxx, Xxxxxxxx
00000 (“MidCap”), as collateral agent (“Agent”),
SILICON VALLEY BANK, a California corporation and
with a loan production office located at 0000
Xxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxx Xxxxx,
Xxxxxxxxxx 00000 (“SVB”), the Lenders listed on
Schedule 1.1 hereof and otherwise party hereto from
time to time (each a “Lender” and collectively, the
“Lenders”) and BIOLASE TECHNOLOGY, INC., a Delaware
corporation (“Borrower”) provides the terms on
which Lenders shall lend to Borrower and Borrower
shall repay Lenders. The parties agree as follows:
1 ACCOUNTING AND OTHER TERMS
Accounting terms not defined in this Agreement
shall be construed following GAAP. Calculations
and determinations must be made following GAAP.
Capitalized terms not otherwise defined in this
Agreement shall have the meanings set forth in
Section 14. All other terms contained in this
Agreement, unless otherwise indicated, shall have
the meaning provided by the Code to the extent
such terms are defined therein.
2 LOAN AND TERMS OF PAYMENT
2.1 Promise to Pay. Borrower hereby unconditionally promises to pay to Agent, for
payment to each Lender in accordance with its respective Pro Rata Share, the outstanding principal
amount of all Credit Extensions made by the Lenders and accrued and unpaid interest thereon and any
other amounts due hereunder as and when due in accordance with this Agreement.
2.2 Term Loans.
(a) Availability. Subject to the terms and conditions of this Agreement, the Lenders agree,
severally and not jointly, to make term loans to Borrower in an aggregate amount up to Five Million
Dollars ($5,000,000.00) according to each Lender’s Term Loan Commitment as set forth on Schedule
1.1 hereto. The Term Loans shall be available in two tranches. The first tranche (“Term A Loan”)
shall be in an amount equal to Three Million Dollars ($3,000,000.00) and shall be advanced on the
Effective Date. The second tranche (“Term B Loan”; Term A Loan and Term B Loan are each referred
to herein individually as a “Term Loan” and collectively as the “Term Loans”) shall be made
available by the Lenders during the Term B Loan Draw Period in an amount equal to Two Million
Dollars ($2,000,000.00) in a single advance. In the event Borrower does not request the Term B Loan
during the Term B Loan Draw Period, Lenders may advance the Term B Loan to Borrower within five (5)
Business Days after the end of the Term B Loan Draw Period without such request by Borrower, after
which advance Borrower will be deemed to have received said Term Loan B for all purposes hereafter.
After repayment, no Term Loan may be re-borrowed.
(b) Interest Payments and Repayment. Commencing on the first (1st) Payment Date
following the Funding Date of Term A Loan, and continuing on the Payment Date of each successive
month thereafter through and including the Maturity Date, Borrower shall make monthly payments of
interest to Agent, for payment to each Lender in accordance with its respective Pro Rata Share, in
arrears, and calculated as set forth in Section 2.3. Commencing on the Amortization Date, and
continuing on the Payment Date of each successive month thereafter through and including the
Maturity Date, Borrower shall make consecutive monthly payments of principal to Agent, for payment
to each Lender in accordance with its respective Pro Rata Share, as calculated by Agent based upon:
(1) the amount of such Lender’s Term Loans, (2) the effective rate of interest, as determined in
Section 2.3, and (3) a straight-line amortization schedule ending on the Maturity Date. All
unpaid principal and accrued interest with respect to the Term Loans is due and payable in full on
the Maturity Date. The Term Loans may be prepaid only in accordance with Sections 2.2(c) and
2.2(d).
(c) Mandatory Prepayments. If the Term Loans are accelerated following the occurrence of an
Event of Default, Borrower shall immediately pay to Agent, for payment to each Lender in accordance
with its
respective Pro Rata Share, an amount equal to the sum of: (i) all outstanding principal of the
Term Loans and all other Obligations, plus accrued and unpaid interest thereon, (ii) the Final
Payment, (iii) the Prepayment Fee, plus (iv) all other sums that shall have become due and payable,
including Lenders’ Expenses.
(d) Permitted Prepayment of Loans. Borrower shall have the option to prepay all, but not
less than all, of the Term Loans advanced by the Lenders under this Agreement, provided Borrower
(i) provides written notice to Agent of its election to prepay the Term Loans at least thirty (30)
days prior to such prepayment, and (ii) pays to Agent, for payment to each Lender in accordance
with its respective Pro Rata Share, on the date of such prepayment, an amount equal to the sum of
(A) all outstanding principal of the Term Loans and all other Obligations, plus accrued interest
thereon, (B) the Final Payment, (C) the Prepayment Fee, and (D) all other sums that shall have
become due and payable, including Lenders’ Expenses.
2.3 Payment of Interest on the Credit Extensions.
(a) Computation of Interest. Interest on the Credit Extensions and all fees payable hereunder
shall be computed on the basis of a 360-day year and the actual number of days elapsed in the
period during which such interest accrues. In computing interest on any Credit Extension, the date
of the making of such Credit Extension shall be included and the date of payment shall be excluded;
provided, however, that if any Credit Extension is repaid on the same day on which it is made, such
day shall be included in computing interest on such Credit Extension.
(b) Interest Rate Determination. Subject to the provisions of Section 2.3(c) below, each
Advance shall bear interest on the outstanding principal amount thereof from the date when made
until paid in full at a rate per annum equal to the (i) the greater of (A) the LIBOR Rate in effect
for the applicable Interest Period or (B) three percent (3.00%), plus (ii) the LIBOR Rate Margin,
adjusted on the first (1st) day of each Interest Period and fixed for the duration of
each such Interest Period. As of each Interest Rate Determination Date, Agent shall determine
(which determination shall, absent manifest error in calculation, be final, conclusive and binding
upon all parties) the interest rate that shall apply to the Advances for which an interest rate is
then being determined for the applicable Interest Period. In the event that Agent shall have
determined (which determination shall be final and conclusive and binding upon all parties hereto),
as of any Interest Rate Determination Date with respect to any Advance, that adequate and fair
means do not exist for ascertaining the interest rate applicable to such Advance on the basis
provided for in the definition of Base LIBOR Rate, then Agent may select a comparable replacement
index and corresponding margin.
(c) Default Rate. Immediately upon the occurrence and during the continuance of an Event of
Default, Obligations shall bear interest at a rate per annum which is five percentage points
(5.00%) above the rate that is otherwise applicable thereto (the “Default Rate”). Payment or
acceptance of the increased interest rate provided in this Section 2.3(c) is not a permitted
alternative to timely payment and shall not constitute a waiver of any Event of Default or
otherwise prejudice or limit any rights or remedies of Agent or Lenders.
(d) Debit of Accounts. Lenders may debit any of Borrower’s deposit accounts, including the
Designated Deposit Account, for principal and interest payments when due or any other amounts
Borrower owes the Lenders under the Loan Documents when due. These debits shall not constitute a
set-off.
(e) Payments. Payments of principal and/or interest received after 12:00 noon Eastern time
are considered received at the opening of business on the next Business Day. When a payment is due
on a day that is not a Business Day, the payment is due the next Business Day and additional fees
or interest, as applicable, shall continue to accrue until paid. All payments to be made by
Borrower hereunder or under any other Loan Document, including payments of principal and interest
made hereunder and pursuant to any other Loan Document, and all fees, expenses, indemnities and
reimbursements, shall be made without set-off, recoupment or counterclaim, in lawful money of the
United States and in immediately available funds. All payments required under this Agreement are
to be made directly to Agent unless otherwise directed by Agent in writing.
2
(f) Maximum Lawful Rate. In no event shall the interest charged hereunder, with respect to
the notes (if any) or any other obligations of Borrower under any Loan Documents exceed the maximum
amount permitted under the Laws of the State of Maryland. Notwithstanding anything to the contrary
herein or elsewhere, if
at any time the rate of interest payable hereunder or under any note or other Loan Document
(the “Stated Rate”) would exceed the highest rate of interest permitted under any applicable Law to
be charged (the “Maximum Lawful Rate”), then for so long as the Maximum Lawful Rate would be so
exceeded, the rate of interest payable shall be equal to the Maximum Lawful Rate; provided,
however, that if at any time thereafter the Stated Rate is less than the Maximum Lawful Rate,
Borrower shall, to the extent permitted by Law, continue to pay interest at the Maximum Lawful Rate
until such time as the total interest received is equal to the total interest which would have been
received had the Stated Rate been (but for the operation of this provision) the interest rate
payable. Thereafter, the interest rate payable shall be the Stated Rate unless and until the
Stated Rate again would exceed the Maximum Lawful Rate, in which event this provision shall again
apply. In no event shall the total interest received by any Lender exceed the amount which it
could lawfully have received, had the interest been calculated for the full term hereof at the
Maximum Lawful Rate. If, notwithstanding the prior sentence, any Lender has received interest
hereunder in excess of the Maximum Lawful Rate, such excess amount shall be applied to the
reduction of the principal balance of such Lender’s Term Loan or to other amounts (other than
interest) payable hereunder, and if no such principal or other amounts are then outstanding, such
excess or part thereof remaining shall be paid to Borrower. In computing interest payable with
reference to the Maximum Lawful Rate applicable to any Lender, such interest shall be calculated at
a daily rate equal to the Maximum Lawful Rate divided by the number of days in the year in which
such calculation is made.
2.4 Fees. Borrower shall pay to Agent for the account of Lenders:
(a) Origination Fee. A fully earned, non-refundable origination fee to be shared among the
Lenders pursuant to their respective Commitment Percentages in an amount equal to one-half of one
percent (0.50%) of the aggregate Term Loan Commitments of the Lenders, which origination fee
Lenders have received prior to the Effective Date;
(b) Final Payment. The Final Payment, when due under Section 2.2(c) or 2.2(d), or otherwise
on the Maturity Date, to be shared among the Lenders in accordance with their respective Pro Rata
Shares;
(c) Prepayment Fee. The Prepayment Fee, when due hereunder, to be shared among the Lenders in
accordance with their respective Pro Rata Shares;
(d) Payment Upon Failure to Draw. In the event that the (i) the Equity Event occurs on or
prior to August 31, 2010 and (ii) Term B Loan is not funded by Lenders to Borrower in an amount
equal to the full amount of the Term B Loan Commitment on the date which is ten (10) Business Days
after the closing of the Equity Event, then, on the such date, Borrower shall pay Agent, for the
benefit of the Lenders in accordance with their respective Pro Rata Shares, a fee in an amount
equal to five percent (5.00%) of the unfunded portion of the Term B Loan Commitment; and
(e) Lenders’ Expenses. All Lenders’ Expenses (including reasonable attorneys’ fees and
expenses for documentation and negotiation of this Agreement) incurred through and after the
Effective Date, when due (and in the absence of any other due date specified herein, such Lenders’
Expenses shall be due upon demand).
2.5 Additional Costs. If any new Law or regulation increases a Lender’s costs or
reduces its income for any Term Loan, Borrower shall pay the increase in cost or reduction in
income or additional expense; provided, however, that Borrower shall not be liable for any amount
attributable to any period before one hundred eighty (180) days prior to the date such Lender
notifies Borrower of such increased costs. Each Lender agrees that it shall allocate any increased
costs among its customers similarly affected in good faith and in a manner consistent with such
Lender’s customary practice.
3
2.6 Payments and Taxes. Any and all payments made by Borrower under this Agreement or
any Loan Documents shall be made free and clear of and without deduction for any and all present or
future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges
imposed by any governmental authority (including any interest, additions to tax or penalties
applicable thereto) other than any taxes imposed on or measured by any Lender’s overall net income
and franchise taxes imposed on it (in lieu of net income taxes), by a jurisdiction (or any
political subdivision thereof) as a result of any Lender being organized or resident, conducting
business (other than a business deemed to arise from such Lender having executed, delivered or
performed its obligations or received a payment under, or enforced, or
otherwise with respect to, this Agreement or any Loan Documents) or having its principal
office in such jurisdiction (“Indemnified Taxes”). If any Indemnified Taxes shall be required by
Law to be withheld or deducted from or in respect of any sum payable under this Agreement or any
Loan Documents to any Lender (w) an additional amount shall be payable as may be necessary so that,
after making all required withholdings or deductions (including withholdings or deductions
applicable to additional sums payable under this Section) such Lender receives an amount equal to
the sum it would have received had no such withholdings or deductions been made, (x) Borrower shall
make such withholdings or deductions, (y) Borrower shall pay the full amount withheld or deducted
to the relevant taxing authority or other authority in accordance with applicable Law and (z)
Borrower shall deliver to such Lender evidence of such payment. Borrower’s obligation hereunder
shall survive the termination of this Agreement.
2.7 Secured Promissory Notes. Each Term Loan shall be evidenced by a Secured
Promissory Note in the form attached as Exhibit D hereto (each a “Secured Promissory Note”), and
shall be repayable as set forth herein. Borrower irrevocably authorizes each Lender to make or
cause to be made, on or about the Funding Date of any Term Loan or at the time of receipt of any
payment of principal on such Lender’s Secured Promissory Note, an appropriate notation on such
Lender’s Secured Promissory Note Record reflecting the making of such Term Loan or (as the case may
be) the receipt of such payment. The outstanding amount of each Term Loan set forth on such
Lender’s Secured Promissory Note Record shall be prima facie evidence of the principal amount
thereof owing and unpaid to such Lender, but the failure to record, or any error in so recording,
any such amount on such Lender’s Secured Promissory Note Record shall not limit or otherwise affect
the obligations of Borrower hereunder or under any Secured Promissory Note to make payments of
principal of or interest on any Secured Promissory Note when due. Upon receipt of an affidavit of
an officer of a Lender as to the loss, theft, destruction, or mutilation of its Secured Promissory
Note, Borrower shall issue, in lieu thereof, a replacement Secured Promissory Note in the same
principal amount thereof and of like tenor.
3 CONDITIONS OF LOANS
3.1 Conditions Precedent to Initial Credit Extension. Each Lender’s obligation to
make a Term Loan is subject to the condition precedent that Agent shall consent to or shall have
received, in form and substance satisfactory to Agent and Lenders, such documents, and completion
of such other matters, as Agent may reasonably deem necessary or appropriate, including, without
limitation:
(a) duly executed original signatures to the Loan Documents to which Borrower is a party;
(b) [reserved];
(c) duly executed original Secured Promissory Notes in favor of each Lender with a face amount
equal to such Lender’s Term Loan Commitment;
(d) the Operating Documents of Borrower and good standing certificates of Borrower certified
by the Secretary of State of the State of Delaware as of a date no earlier than thirty (30) days
prior to the Effective Date;
(e) good standing certificates dated as of a date no earlier than thirty (30) days prior to
the Effective Date to the effect that Borrower is qualified to transact business in all states in
which the nature of Borrower’s business so requires;
(f) duly executed original signatures to the completed Borrowing Resolutions for Borrower;
(g) certified copies, dated as of a recent date, of financing statement searches, as Agent
shall request, accompanied by written evidence (including any UCC termination statements) that the
Liens indicated in any such financing statements either constitute Permitted Liens or have been or,
in connection with the initial Credit Extension, will be terminated or released;
(h) the Perfection Certificate executed by Borrower;
4
(i) a landlord’s consent executed in favor of Agent in respect of Borrower’s leased location
in Irvine, California;
(j) a legal opinion of Borrower’s counsel dated as of the Effective Date together with the
duly executed original signatures thereto;
(k) copies of any existing registration rights agreement/investors’ rights agreement or
similar agreements and any amendments thereto;
(l) evidence satisfactory to Agent that the insurance policies required by Section 6.5 hereof
are in full force and effect, together with appropriate evidence showing loss payable and/or
additional insured clauses or endorsements in favor of Agent, for the ratable benefit of Lenders;
and
(m) payment of the fees and Lenders’ Expenses then accrued as specified in Section 2.4 hereof.
3.2 Conditions Precedent to all Credit Extensions. The obligation of each Lender to
make each Credit Extension, including the initial Credit Extension, is subject to the following
conditions precedent:
(a) timely receipt by Agent of an executed Payment/Advance Form in the form of Exhibit B
attached hereto;
(b) the representations and warranties in Section 5 shall be true, correct and complete in all
material respects on the date of the Payment/Advance Form and on the Funding Date of each Credit
Extension; provided, however, that such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text
thereof; and provided, further that those representations and warranties expressly referring to a
specific date shall be true, accurate and complete in all material respects as of such date, and no
Default or Event of Default shall have occurred and be continuing or result from the Credit
Extension. Each Credit Extension is Borrower’s representation and warranty on that date that the
representations and warranties in Section 5 remain true, accurate and complete in all material
respects; provided, however, that such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text
thereof; and provided, further that those representations and warranties expressly referring to a
specific date shall be true, accurate and complete in all material respects as of such date; and
(c) in such Lender’s reasonable discretion, there has not been any Material Adverse Change or
any material impairment in the general affairs, management, results of operation, financial
condition or the prospect of repayment of the Obligations, or any material adverse deviation by
Borrower from the most recent business plan of Borrower presented to and accepted by Agent.
3.3 Covenant to Deliver. Borrower agrees to deliver to Agent each item required to be
delivered to Agent under this Agreement as a condition precedent to any Credit Extension. Borrower
expressly agrees that a Credit Extension made prior to the receipt by Agent of any such item shall
not constitute a waiver by the Lenders of Borrower’s obligation to deliver such item, and any such
Credit Extension in the absence of a required item shall be made in Agent’s sole discretion.
3.4 Procedures for Borrowing. Subject to the prior satisfaction of all other
applicable conditions to the making of a Term Loan set forth in this Agreement, to obtain a Term
Loan, Borrower shall notify Agent (which notice shall be irrevocable) by electronic mail,
facsimile, or telephone by 12:00 noon Eastern time three (3) Business Days prior to the date the
Term Loan is to be made. Together with any such electronic or facsimile notification, Borrower
shall deliver to Agent by electronic mail or facsimile a completed Payment/Advance Form executed by
a Responsible Officer or his or her designee. Upon receipt of a Payment/Advance Form, Agent shall
promptly provide a copy of the same to each Lender. Agent may rely on any telephone notice given
by a person whom Agent reasonably believes is a Responsible Officer or designee.
5
4 CREATION OF SECURITY INTEREST
4.1 Grant of Security Interest. Borrower hereby grants Agent, for the ratable benefit
of Lenders, to secure the payment and performance in full of all of the Obligations, a continuing
security interest in, and pledges to Agent, for the ratable benefit of the Lenders, the Collateral,
wherever located, whether now owned or hereafter acquired or arising, and all proceeds and products
thereof. Borrower represents, warrants, and covenants that, upon the execution and delivery of the
a Subordination Agreement by Xxxxx Xxxxxx on or prior to the Effective Date, the security interest
granted herein is and shall at all times continue to be a first priority perfected security
interest in the Collateral, subject only to Permitted Liens that may have priority by operation of
applicable Law. If Borrower shall acquire a commercial tort claim (as defined in the Code),
Borrower shall promptly notify Agent in a writing signed by Borrower of the general details thereof
(and further details as may be required by Agent) and grant to Agent, for the ratable benefit of
the Lenders, in such writing a security interest therein and in the proceeds thereof, all upon the
terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to
Agent.
4.2 Authorization to File Financing Statements; Termination of Financing Statements.
Borrower hereby authorizes Agent to file financing statements, without notice to Borrower, with all
appropriate jurisdictions to perfect or protect Agent’s and each Lender’s interest or rights
hereunder, including a notice that any disposition of the Collateral, by either Borrower or any
other Person, shall be deemed to violate the rights of Agent and the Lenders under the Code. Such
financing statements may indicate the Collateral as “all assets of Debtor” or words of similar
effect, or as being of an equal or lesser scope, or with greater detail, all in Agent’s discretion
Upon payment in full of (i) all outstanding principal of the Term Loans and all other Obligations,
plus accrued and unpaid interest thereon, (ii) the Final Payment, (iii) the Prepayment Fee, plus
(iv) any and all other sums that shall have become due and payable, including Lenders’ Expenses,
and provided that Lenders have no further obligation or commitment to lend hereunder, Agent and
Lenders shall promptly file termination statements relating to the Collateral.
5 REPRESENTATIONS AND WARRANTIES
Borrower represents and warrants as follows at all times unless expressly provided below:
5.1 Due Organization, Authorization: Power and Authority.
(a) Borrower and each of its Subsidiaries, if any, are duly existing and in good standing, as
Registered Organizations in their respective jurisdictions of formation and are qualified and
licensed to do business and are in good standing in any jurisdiction in which the conduct of their
business or their ownership of property requires that they be qualified except where the failure to
do so could not reasonably be expected to have a material adverse effect on Borrower’s business.
In connection with this Agreement, Borrower has delivered to Agent a completed perfection
certificate signed by Borrower (the “Perfection Certificate”). Borrower represents and warrants
that (a) Borrower’s exact legal name is that indicated on the Perfection Certificate and on the
signature page hereof; (b) Borrower is an organization of the type and is organized in the
jurisdiction set forth in the Perfection Certificate; (c) the Perfection Certificate accurately
sets forth Borrower’s organizational identification number or accurately states that Borrower has
none; (d) the Perfection Certificate accurately sets forth Borrower’s place of business, or, if
more than one, its chief executive office as well as Borrower’s mailing address (if different than
its chief executive office); (e) Borrower (and each of its predecessors) has not, in the past five
(5) years, changed its jurisdiction of formation, organizational structure or type, or any
organizational number assigned by its jurisdiction; and (f) all other information set forth on the
Perfection Certificate pertaining to Borrower and each of its Subsidiaries is accurate and complete
in all material respects (it being understood and agreed that Borrower may from time to time update
certain information in the Perfection Certificate after the Effective Date to the extent permitted
by one or more specific provisions in this Agreement). If Borrower is not now a Registered
Organization but later becomes one, Borrower shall promptly notify Agent of such occurrence and
provide Agent with Borrower’s organizational identification number.
(b) The execution, delivery and performance by Borrower of the Loan Documents to which it is a
party have been duly authorized, and do not (i) conflict with any of Borrower’s organizational
documents, (ii) contravene, conflict with, constitute a default under or violate any material
Requirement of Law, (iii) contravene, conflict or violate any applicable order, writ, judgment,
injunction, decree, determination or award of any Governmental Authority by which Borrower or any
of its Subsidiaries or any of their property or assets may be bound or affected, (iv) require any
action by, filing, registration, or qualification with, or Governmental Approval from, any
Governmental Authority (except such Governmental Approvals which have already been obtained and are
in full force and effect), or (v) constitute an event of default under any material agreement
by which Borrower or any of its Subsidiaries or their respective properties is bound. Borrower is
not in default under any agreement to which it is a party or by which it is bound in which the
default could reasonably be expected to have a material adverse effect on Borrower’s business.
6
5.2 Collateral.
(a) Borrower has good title to, has rights in, and has the power to transfer each item of the
Collateral upon which it purports to xxxxx x Xxxx hereunder, free and clear of any and all Liens
except Permitted Liens. Other than the accounts referred to in the last section of Section 6.6(b)
hereof, Borrower has no Deposit Accounts, Securities Accounts, Commodity Accounts or other
investment accounts other than the Collateral Accounts with Comerica Bank and SVB or the other
investment accounts, if any, described in the Perfection Certificate delivered to Agent in
connection herewith with respect of which Borrower has given Agent notice and taken such actions as
are necessary to give Agent for the ratable benefit of all Lenders a perfected security interest
therein. The Accounts are bona fide, existing obligations of the Account Debtors.
(b) On the Effective Date, the Collateral is not in the possession of any third party bailee
(such as a warehouse) except as disclosed in the Perfection Certificate or Schedule 5.2(b), and, as
of the Effective Date, no such third party bailee possesses components of the Collateral in excess
of Twenty-Five Thousand Dollars ($25,000). None of the components of the Collateral shall be
maintained at locations other than as disclosed in the Perfection Certificate on the Effective Date
or as permitted pursuant to Section 7.2. In the event that Borrower, after the Effective Date,
intends to store or otherwise deliver any portion of the Collateral to a bailee in excess of Fifty
Thousand Dollars ($50,000), then Borrower will first receive the written consent of Agent and such
bailee must execute and deliver a bailee agreement in form and substance satisfactory to Agent in
its sole discretion.
(c) All Inventory is in all material respects of good and marketable quality, free from
material defects.
(d) Borrower is the sole owner of its Intellectual Property, except for non-exclusive licenses
granted to its customers in the ordinary course of business and those licenses described in the
Perfection Certificate. Each Patent is valid and enforceable and no part of the Intellectual
Property has been judged invalid or unenforceable, in whole or in part, and, except as set forth on
Schedule 5.2(d), to the best of Borrower’s knowledge, no claim has been made that any part of the
Intellectual Property violates the rights of any third party except to the extent such claim could
not reasonably be expected to have a material adverse effect on Borrower’s business.
(e) Except as noted on the Perfection Certificate, Borrower is not a party to, nor is bound
by, any material license or other agreement with respect to which Borrower is a licensee that (a)
prohibits or otherwise restricts Borrower from granting a security interest in Borrower’s interest
in such license or agreement or any other property, or (b) for which a default under or termination
of could interfere with Agent’s right to sell any Collateral. Borrower shall provide written
notice to Agent within ten (10) days of entering or becoming bound by any such license or agreement
(other than over-the-counter software that is commercially available to the public). Borrower
shall take such steps as Agent requests to obtain the consent of, or waiver by, any person whose
consent or waiver is necessary for (x) all such licenses or agreements to be deemed “Collateral”
and for Agent to have a security interest in it that might otherwise be restricted or prohibited by
Law or by the terms of any such license or agreement, whether now existing or entered into in the
future, and (y) Agent to have the ability in the event of a liquidation of any Collateral to
dispose of such Collateral in accordance with Agent’s rights and remedies under this Agreement and
the other Loan Documents.
(f) All of Borrower’s Material Intellectual Property, including all licenses under which
Borrower is the licensee of any such Material Intellectual Property owned by another Person, are
set forth on Schedule 5.2(f). Such Schedule 5.2(f) indicates in each case the expiration date of
such Material Intellectual Property and whether such Material Intellectual Property (or application
therefor) is owned or licensed by Borrower, and in the case of any such licensed Material
Intellectual Property, lists the name and address of the licensor and the name and date of the
agreement pursuant to which such item of Material Intellectual Property is licensed, the expiration
date of such license and the expiration date of the underlying Material Intellectual Property,
whether or
not such license is an exclusive license and whether there are any purported restrictions in
such license on the ability to Borrower to grant a security interest in and/or to transfer any of
its rights as a licensee under such license.
7
5.3 Litigation. Except as disclosed in the Perfection Certificate or Schedule 5.3,
there are no actions or proceedings pending or, to the knowledge of the Responsible Officers,
threatened in writing by or against Borrower or any of its Subsidiaries involving more than One
Hundred Thousand Dollars ($100,000.00).
5.4 No Material Deterioration in Financial Condition; Financial Statements. All
consolidated financial statements for Borrower and any of its Subsidiaries delivered to Agent
fairly present, in conformity with GAAP, in all material respects Borrower’s consolidated financial
condition and Borrower’s consolidated results of operations. There has not been any material
deterioration in Borrower’s consolidated financial condition since the date of the most recent
unaudited financial statements and projections submitted to Agent and the Lenders (which as of the
Effective Date were (i) Borrower’s March 31, 2010 unaudited financial statements delivered to
Agent and the Lenders on May 6, 2010, (ii) Borrower’s financial projections delivered to Agent and
the Lenders on April 19, 2010 and (iii) Borrower’s cash balance delivered to Agent and the Lenders
on May 24, 2010).
5.5 Solvency. The fair salable value of Borrower’s assets (including goodwill minus
disposition costs) exceeds the fair value of its liabilities; Borrower is not left with
unreasonably small capital after the transactions in this Agreement; and Borrower is able to pay
its debts (including trade debts) as they mature.
5.6 Regulatory Compliance.
(a) Borrower is not an “investment company” or a company “controlled” by an “investment
company” under the Investment Company Act of 1940, as amended. Borrower is not engaged as one of
its important activities in extending credit for margin stock (under Regulations X, T and U of the
Federal Reserve Board of Governors). Borrower has complied in all material respects with the
Federal Fair Labor Standards Act. Neither Borrower nor any of its Subsidiaries is a “holding
company” or an “affiliate” of a “holding company” or a “subsidiary company” of a “holding company”
as each term is defined and used in the Public Utility Holding Company Act of 2005. Borrower has
not violated any Laws, ordinances or rules, the violation of which could reasonably be expected to
have a material adverse effect on its business. None of Borrower’s or any of its Subsidiaries’
properties or assets has been used by Borrower or any Subsidiary or, to Borrower’s knowledge, by
previous Persons, in disposing, producing, storing, treating, or transporting any hazardous
substance other than in material compliance with applicable Laws. Borrower has obtained all
Required Permits, or has contracted with third parties holding Required Permits, necessary for
compliance with all Laws and all such Required Permits are current. Borrower and each of its
Subsidiaries have obtained all consents, approvals and authorizations of, made all declarations or
filings with, and given all notices to, all Governmental Authorities that are necessary to continue
their respective businesses as currently conducted.
(b) None of Borrower, its Affiliates or any of their respective agents acting or benefiting in
any capacity in connection with the transactions contemplated by this Agreement is (i) in violation
of any Anti-Terrorism Law, (ii) engages in or conspires to engage in any transaction that evades or
avoids, or has the purpose of evading or avoiding or attempts to violate, any of the prohibitions
set forth in any Anti-Terrorism Law, or (iii) is a Blocked Person. Neither Borrower nor, to the
knowledge of Borrower, any of its Affiliates or agents acting or benefiting in any capacity in
connection with the transactions contemplated by this Agreement, (x) conducts any business or
engages in making or receiving any contribution of funds, goods or services to or for the benefit
of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any
property or interest in property blocked pursuant to Executive Order No. 13224, any similar
executive order or other Anti-Terrorism Law.
5.7 Subsidiaries; Investments. Borrower does not own any stock, partnership interest
or other equity securities except for Permitted Investments.
8
5.8 Tax Returns and Payments; Pension Contributions. Borrower has timely filed all
required tax returns and reports, and Borrower and its Subsidiaries have timely paid all foreign,
federal, state and local taxes, assessments, deposits and contributions owed by Borrower. Borrower
may defer payment of any contested taxes, provided that Borrower (a) in good faith contests its
obligation to pay the taxes by appropriate proceedings promptly and diligently instituted and
conducted, (b) notifies Agent in writing of the commencement of, and any material development in,
the proceedings, and (c)
posts bonds or takes any other steps required to prevent the governmental authority levying
such contested taxes from obtaining a Lien upon any of the Collateral that is other than a
“Permitted Lien”. Borrower is unaware of any claims or adjustments proposed for any of Borrower’s
prior tax years which could result in additional taxes becoming due and payable by Borrower.
Borrower has paid all amounts necessary to fund all present pension, profit sharing and deferred
compensation plans in accordance with their terms, and Borrower has not withdrawn from
participation in, and has not permitted partial or complete termination of, or permitted the
occurrence of any other event with respect to, any such plan which could reasonably be expected to
result in any liability of Borrower, including any liability to the Pension Benefit Guaranty
Corporation or its successors or any other governmental agency.
5.9 Use of Proceeds. Borrower shall use the proceeds of the Credit Extensions solely
as working capital and to fund its general business requirements and not for personal, family,
household or agricultural purposes.
5.10 Full Disclosure. No written representation, warranty or other statement of
Borrower in any certificate or written statement given to Agent or any Lender, as of the date such
representation, warranty, or other statement was made, taken together with all such written
certificates and written statements given to Agent or any Lender, contains any untrue statement of
a material fact or omits to state a material fact necessary to make the statements contained in the
certificates or statements not misleading (it being recognized that the projections and forecasts
provided by Borrower in good faith and based upon reasonable assumptions are not viewed as facts
and that actual results during the period or periods covered by such projections and forecasts may
differ from the projected or forecasted results).
5.11 Regulatory Developments.
(a) All Products and all Required Permits are listed on Schedule 5.11 (as updated from time to
time pursuant to Section 6.2(e)), and Borrower has delivered to Agent a copy of all Required
Permits to the extent requested by Agent pursuant to Section 6.2(e);
(b) Without limiting the generality of Section 5.6 above, with respect to any Product being
tested or manufactured by Borrower, Borrower has received, and such Product is the subject of, all
Required Permits needed in connection with the testing or manufacture of such Product as such
testing is currently being conducted by or on behalf of Borrower, and Borrower has not received any
notice from any applicable Governmental Authority, specifically including the FDA, that such
Governmental Authority is conducting an investigation or review of (A) Borrower’s manufacturing
facilities and processes for such Product which have disclosed any material deficiencies or
violations of Laws and/or the Required Permits related to the manufacture of such Product, or (B)
any such Required Permit or that any such Required Permit has been revoked or withdrawn, nor has
any such Governmental Authority issued any order or recommendation stating that the development,
testing and/or manufacturing of such Product by Borrower should cease;
(c) Without limiting the generality of Section 5.6 above, with respect to any Product marketed
or sold by Borrower, Borrower has received, and such Product is the subject of, all Required
Permits needed in connection with the marketing and sales of such Product as currently being
marketed or sold by Borrower, and Borrower has not received any notice from any applicable
Governmental Authority, specifically including the FDA, that such Governmental Authority is
conducting an investigation or review of any such Required Permit or approval or that any such
Required Permit has been revoked or withdrawn, nor has any such Governmental Authority issued any
order or recommendation stating that such marketing or sales of such Product cease or that such
Product be withdrawn from the marketplace;
(d) Without limiting the generality of Section 5.6 above, (i) there have been no adverse
clinical test results which have or could reasonably be expected to cause a Material Adverse
Change, and (ii) there have been no Product recalls or voluntary Product withdrawals from any
market; and
(e) Borrower has not (since the Effective Date) experienced any significant failures in its
manufacturing of any Product such that the amount of such Product successfully manufactured by
Borrower in accordance with all specifications thereof and the required payments related thereto in
any month shall decrease significantly with respect to the quantities of such Product produced in
the prior month.
9
5.12 Non-Operating Subsidiaries. BL Acquisition and BL Acquisition II (i) do not,
individually or collectively, conduct any activities which are material to the operation of the
business of Borrower, own any material amount of assets or own any assets which are material to the
operation of the business, or maintain any Collateral Accounts and (ii) are not obligated in
respect of any Indebtedness, other than Indebtedness incurred pursuant to the Loan Documents.
6 AFFIRMATIVE COVENANTS
Borrower shall do all of the following:
6.1 Government Compliance.
(a) Maintain its and all its Subsidiaries’ legal existence and good standing in their
respective jurisdictions of formation and maintain qualification in each jurisdiction in which the
failure to so qualify could reasonably be expected to have a material adverse effect on Borrower’s
business or operations. Borrower shall comply, and have each Subsidiary comply, with all Laws,
ordinances and regulations to which it is subject, the noncompliance with which could reasonably be
expected to have a material adverse effect on Borrower’s business.
(b) Obtain and keep in full force and effect, all of the Governmental Approvals necessary for
the performance by Borrower of its obligations under the Loan Documents to which it is a party and
the grant of a security interest to Agent for the ratable benefit of the Lenders, in all of the
Collateral. Borrower shall promptly provide copies of any such obtained Governmental Approvals to
Agent.
(c) In connection with the development, testing, manufacture, marketing or sale of each and
any Product by Borrower, Borrower shall comply fully and completely in all respects with all
Required Permits at all times issued by any Governmental Authority the noncompliance with which
could have a material adverse effect on Borrower’s business, specifically including the FDA, with
respect to such development, testing, manufacture, marketing or sales of such Product by Borrower
as such activities are at any such time being conducted by Borrower.
6.2 Financial Statements, Reports, Certificates.
(a) Deliver to Agent: (i) as soon as available, but no later than thirty (30) days after the
last day of each month, a company prepared consolidated balance sheet and income statement covering
Borrower’s consolidated operations for such month certified by a Responsible Officer and in a form
acceptable to Agent; (ii) as soon as available, but no later than one hundred twenty (120) days
after the last day of Borrower’s fiscal year, audited consolidated financial statements prepared
under GAAP, consistently applied, together with an unqualified (other than a “going
concern” qualification) opinion on the financial statements from Borrower’s independent certified
public accounting firm acceptable to Agent in its reasonable discretion; (iii) as soon as available
after approval thereof by Borrower’s Board of Directors, but no later than sixty (60) days after
the last day of Borrower’s fiscal year, Borrower’s financial projections for current fiscal year as
approved by Borrower’s Board of Directors; (iv) within five (5) days of delivery, copies of all
statements, reports and notices made available to all of Borrower’s security holders or to any
holders of Subordinated Debt; (v) within five (5) days of filing, all reports on Form 10-K, 10-Q
and 8-K filed with the Securities and Exchange Commission or a link thereto on Borrower’s or
another website on the Internet; (vi) a prompt report of any legal actions pending or threatened
against Borrower or any of its Subsidiaries that could result in damages or costs to Borrower or
any of its Subsidiaries of One Hundred Thousand Dollars ($100,000) or more or could result in a
Material Adverse Change; and (vii) budgets, sales projections, operating plans and other financial
information as reasonably requested in writing by Agent.
(b) Within thirty (30) days after the last day of each month, deliver to Agent with the
monthly financial statements, a duly completed Compliance Certificate signed by a Responsible
Officer.
10
(c) Keep proper books of record and account in accordance with GAAP in which full, true and
correct entries shall be made of all dealings and transactions in relation to its business and
activities. Borrower shall allow, at the sole cost of Borrower, Agent and Lenders to visit and
inspect any of its properties, to examine and make abstracts or copies from any of its books and
records, to conduct a collateral audit and analysis of its
operations and the Collateral, to verify the amount and age of the accounts, the identity and
credit of the respective account debtors, to review the billing practices of Borrower and to
discuss its respective affairs, finances and accounts with their respective officers, employees and
independent public accountants as often as may reasonably be desired. Notwithstanding the
foregoing, such audits shall be conducted at Borrower’s expense no more often than once every six
(6) months unless a Default or Event of Default has occurred and is continuing.
(d) Deliver to Agent an updated Schedule 5.2(f) promptly upon Borrower’s acquisition or
development of any Material Intellectual Property not already listed on Schedule 5.2(f) and upon
any other material change in Borrower’s Material Intellectual Property from that listed on Schedule
5.2(f).
(e) If after the Effective Date, Borrower determines to manufacture, sell, develop, test or
market any new Product, Borrower shall give written notice to Agent of such new Product following
such Product’s introduction to the general marketplace (which shall include a brief description of
such Product, plus a list of all Required Permits relating to such new Product (and a copy of such
Required Permits if requested by Agent) and/or Borrower’s manufacture, sale, development, testing
or marketing thereof issued or outstanding as of the date of such notice) along with a copy of an
amended and restated Schedule 5.11; and further, provided, that, if Borrower shall at any time
obtain any new or additional Required Permits from the FDA, DEA, or parallel state or local
authorities, or foreign counterparts of the FDA, DEA, or parallel state or local authorities, with
respect to any Product which has previously been disclosed to Agent, Borrower shall promptly give
written notice to Agent of such new or additional Required Permits (along with a copy thereof if
requested by Agent).
6.3 Inventory; Returns. Keep all Inventory in good and marketable condition, free
from material defects. Returns and allowances between Borrower and its Account Debtors shall
follow Borrower’s customary practices as they exist at the Effective Date. Borrower must promptly
notify Agent of all returns, recoveries, disputes and claims that involve more than One Hundred
Thousand Dollars ($100,000).
6.4 Taxes; Pensions. Timely file and require each of its Subsidiaries to timely file,
all required tax returns and reports and timely pay, and require each of its Subsidiaries to timely
file, all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by
Borrower and each of its Subsidiaries, except for deferred payment of any taxes contested pursuant
to the terms of Section 5.8 hereof, and shall deliver to Agent, on demand, appropriate certificates
attesting to such payments, and pay all amounts necessary to fund all present pension, profit
sharing and deferred compensation plans in accordance with their terms.
6.5 Insurance. Keep its business and the Collateral insured for risks and in amounts
standard for companies in Borrower’s industry and location and as Agent may reasonably request.
Insurance policies shall be in a form, with companies, and in amounts that are satisfactory to
Agent. All property policies shall have a lender’s loss payable endorsement showing Agent as
lender loss payee and waive subrogation against Agent, and all liability policies shall show, or
have endorsements showing, Agent, as an additional insured. All policies (or the loss payable and
additional insured endorsements) shall provide that the insurer shall endeavor to give Agent at
least thirty (30) days notice before canceling, amending, or declining to renew its policy. At
Agent’s request, Borrower shall deliver certified copies of policies and evidence of all premium
payments. Proceeds payable under any policy shall, at Agent’s option, be payable to Agent on
behalf of the Lenders on account of the Obligations. If Borrower fails to obtain insurance as
required under this Section 6.5 or to pay any amount or furnish any required proof of payment to
third persons and Agent, Agent may make all or part of such payment or obtain such insurance
policies required in this Section 6.5, and take any action under the policies Agent deems prudent.
6.6 Operating Accounts.
(a) Maintain all of Borrower’s and Guarantor’s Collateral Accounts, operating and investment
accounts with Comerica Bank or SVB, which accounts shall be subject to Control Agreements in favor
of Agent for the ratable benefit of all Lenders; provided, that on and after the date which is
twenty-five (25) days after the Effective Date, Borrower and Guarantor shall (i) maintain their
primary operating accounts with SVB and/or one of its Affiliates and (ii) maintain at least 85% of
their aggregate cash and Cash Equivalents with SVB and/or one of its Affiliates.
11
(b) Provide Agent five (5) days prior written notice before establishing any Collateral
Account at or with any bank or financial institution other than Comerica Bank and SVB. In
addition, for each Collateral Account that Borrower at any time maintains, Borrower shall cause the
applicable bank or financial institution at or with which any Collateral Account is maintained to
execute and deliver a Control Agreement or other appropriate instrument with respect to such
Collateral Account to perfect Agent’s Lien in such Collateral Account in accordance with the terms
hereunder, which Control Agreement may not be terminated without prior written consent of Agent.
The provisions of the previous sentence shall not apply to (i) deposit accounts exclusively used
for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of
Borrower’s employees and identified to Agent by Borrower as such and (ii) account(s) maintained
outside of the United States by Borrower, Guarantor or the Foreign Subsidiaries, provided that the
aggregate amount on deposit in all such account(s) shall not at any time exceed $125,000 and the
funds on deposit in such account(s) shall be used exclusively for purposes of funding the
operations of the Foreign Subsidiaries in the ordinary course of business.
6.7 Protection of Intellectual Property Rights. Borrower shall own, or be licensed to
use or otherwise have the right to use, all Material Intellectual Property. All Intellectual
Property of Borrower is and shall be fully protected and/or duly and properly registered, filed or
issued in the appropriate office and jurisdictions for such registrations, filings or issuances,
except where the failure to do so would not reasonably be expected to result in a Material Adverse
Change. Borrower shall not become a party to, nor become bound by, any material license or other
agreement with respect to which Borrower is the licensee that prohibits or otherwise restricts
Borrower from granting a security interest in Borrower’s interest in such license or agreement or
other property. Borrower shall at all times conduct its business without infringement or claim of
infringement of any Intellectual Property rights of others. Borrower shall, to the extent it
determines, in the exercise of its reasonable business judgment, that it is prudent to do the
following: (a) protect, defend and maintain the validity and enforceability of its Intellectual
Property; (b) promptly advise Agent in writing of material infringements of its Intellectual
Property; and (c) not allow any Material Intellectual Property to be abandoned, forfeited or
dedicated to the public without Agent’s prior written consent. If Borrower (i) obtains any patent,
registered trademark or servicemark, registered copyright, registered mask work, or any pending
application for any of the foregoing, whether as owner, licensee or otherwise, or (ii) applies for
any patent or the registration of any trademark or servicemark, then Borrower shall concurrently
provide written notice thereof to Agent and shall execute such intellectual property security
agreements and other documents and take such other actions as Agent shall request in its good faith
business judgment to perfect and maintain a first priority perfected security interest in favor of
Agent, for the ratable benefit of Lenders, in such property. If Borrower decides to register any
copyrights or mask works in the United States Copyright Office, Borrower shall: (x) provide Agent
with at least fifteen (15) days prior written notice of Borrower’s intent to register such
copyrights or mask works together with a copy of the application it intends to file with the United
States Copyright Office (excluding exhibits thereto); (y) execute an intellectual property security
agreement and such other documents and take such other actions as Agent may request in its good
faith business judgment to perfect and maintain a first priority perfected security interest in
favor of Agent, for the ratable benefit of the Lenders, in the copyrights or mask works intended to
be registered with the United States Copyright Office; and (z) record such intellectual property
security agreement with the United States Copyright Office contemporaneously with filing the
copyright or mask work application(s) with the United States Copyright Office. Borrower shall
promptly provide to Agent copies of all applications that it files for patents or for the
registration of trademarks, servicemarks, copyrights or mask works, together with evidence of the
recording of the intellectual property security agreement necessary for Agent, for the ratable
benefit of the Lenders, to perfect and maintain a first priority perfected security interest in
such property.
6.8 Litigation Cooperation. From the date hereof and continuing through the
termination of this Agreement, make available to Agent, without expense to Agent, Borrower and its
officers, employees and agents and Borrower’s Books, to the extent that Agent may deem them
reasonably necessary to prosecute or defend any third-party suit or proceeding instituted by or
against Agent with respect to any Collateral or relating to Borrower.
6.9 Notices of Litigation and Default. Borrower will give prompt written notice to
Agent of any litigation or governmental proceedings pending or threatened (in writing) against
Borrower which would reasonably be expected to have a material adverse effect with respect to
Borrower’s business. Without limiting or contradicting any other more specific provision of this
Agreement, promptly (and in any event within three (3) Business Days) upon Borrower becoming aware
of the existence of any Event of Default or event which, with the giving of notice or passage of
time, or both, would constitute an Event of Default, Borrower shall give written notice to Agent of
such occurrence, which such notice shall include a reasonably detailed description of such Event of
Default or event which, with the giving of notice or passage of time, or both, would constitute an
Event of Default.
12
6.10 Creation/Acquisition of Subsidiaries. In the event Borrower or any Subsidiary
creates or acquires any Subsidiary, Borrower and such Subsidiary shall promptly notify Agent of the
creation or acquisition of such new Subsidiary and take all such action as may be reasonably
required by Agent to cause each such domestic Subsidiary to become a co-Borrower hereunder or to
guarantee the Obligations of Borrower under the Loan Documents and, in each case, grant a
continuing pledge and security interest in and to the assets of such Subsidiary (substantially as
described on Exhibit A hereto); and Borrower shall grant and pledge to Agent, for the ratable
benefit of the Lenders, a perfected security interest in the stock, units or other evidence of
ownership of each Subsidiary.
6.11 Financial Covenants. Maintain at all times, to be tested as of the last day of
each quarter, unless otherwise noted, on a consolidated basis with respect to Borrower:
(a) EBITDA. Achieve EBITDA, tested at the dates noted below for the periods noted
below of at least the following:
Testing Date | Testing Period | Minimum EBITDA | ||||
July 1, 2010 |
April 1, 2010 through June 30, 2010 | $ | (3,029,518 | ) | ||
October 1, 2010 |
April 1, 2010 through September 30, 2010 | $ | (3,602,460 | ) | ||
January 1, 2011 |
April 1, 2010 through December 31, 2010 | $ | (2,534,589 | ) | ||
April 1, 2011 |
April 1, 2010 through March 31, 2011 | $ | (2,417,369 | ) | ||
July 1, 2011 |
July 1, 2010 through June 30, 2011 | $ | 3,910,734 | |||
October 1, 2011 |
October 1, 2010 through September 30, 2011 | $ | 6,744,096 | |||
January 1, 2012 |
January 1, 2011 through December 31, 2011 | $ | 11,535,318 | |||
April 1, 2012 and the first day of each quarter thereafter |
Trailing 12 months | 85% of projected EBITDA as set forth in EBITDA projections delivered by Borrower to Agent and Lenders on or before December 1, 2011, which EBITDA shall be approved by Agent and the Lenders in their discretion |
6.12 Further Assurances.
(a) Execute any further instruments and take further action as Agent reasonably requests to
perfect or continue Agent’s Lien in the Collateral or to effect the purposes of this Agreement.
(b) Deliver to Agent, within five (5) days after the same are sent or received, copies of all
material correspondence, reports, documents and other filings with any Governmental Authority that
could reasonably be expected to have a material effect on any of the Governmental Approvals
material to Borrower’s business or otherwise on the operations of Borrower or any of its
Subsidiaries.
13
6.13 Post-Closing Covenant—Xxxxx Xxxxxx Inc. Subordination Agreement. Within thirty
(30) days of the Effective Date, Borrower shall deliver to Agent a Subordination Agreement duly
executed by Xxxxx Xxxxxx, Inc. in favor of the Lenders in form and substance satisfactory to Agent
(the “Post-Closing Subordination Covenant”). In the event Borrower fails to satisfy the
Post-Closing Subordination Covenant within such thirty (30) day period (as to which no grace period
shall apply) the LIBOR Rate Margin applicable the Advances shall automatically increase as set
forth in the definition “LIBOR Rate Margin”. Such increase in the LIBOR Rate Margin shall be
Lenders’ sole remedy in respect of the Post-Closing Subordination Covenant (i.e., failure to
satisfy the Post-Closing Subordination Covenant shall not constitute an Event of Default).
6.14 Additional Post-Closing Requirements.
(a) Provide to Agent, within thirty (30) days after the Effective Date (or such later date as
Agent may determine, in its reasonable discretion), with a landlord’s consent in favor of Agent for
the following leased location by the respective landlord thereof, together with the duly executed
original signatures thereto:
(i) 0 Xxxxxxxx, Xxxxxx, Xxxxxxxxxx; and
(b) Provide to Agent, within twenty-five (25) days after the Effective Date (or such later
date as Agent may determine, in its reasonable discretion) duly executed original signatures to the
Control Agreements from SVB, and such other financial institutions as Agent may require, in its
sole discretion.
7 NEGATIVE COVENANTS
Borrower shall not do any of the following without the prior written consent of Agent and the
Required Lenders:
7.1 Dispositions. Convey, sell, lease, transfer, assign, or otherwise dispose of
(collectively, “Transfer”), or permit any of its Subsidiaries to Transfer, all or any part of its
business or property, except for Transfers (a) of Inventory in the ordinary course of business; (b)
of worn-out or obsolete Equipment; or (c) in connection with Permitted Liens and Permitted
Investments.
7.2 Changes in Business, Management, Ownership, or Business Locations. (a) Engage in
or permit any of its Subsidiaries to engage in any business other than the businesses currently
engaged in by Borrower and such Subsidiary, as applicable, or reasonably related thereto; (b)
liquidate or dissolve; or (c) permit or suffer any Change in Control. Borrower shall not, without
at least thirty (30) days prior written notice to Agent: (1) add any new offices or business
locations, including warehouses (unless such new offices or business locations contain less than
Twenty Five Thousand Dollars ($25,000) in Borrower’s assets or property), (2) change its
jurisdiction of organization, (3) change its organizational structure or type, (4) change its legal
name, or (5) change any organizational number (if any) assigned by its jurisdiction of
organization.
7.3 Mergers or Acquisitions. Merge or consolidate, or permit any of its Subsidiaries
to merge or consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to
acquire, all or substantially all of the capital stock or property of another Person. A Subsidiary
may merge or consolidate into another Subsidiary (provided such surviving Subsidiary is a
“co-Borrower” hereunder or has provided a secured guaranty hereunder) or into Borrower provided
Borrower is the surviving legal entity and Borrower’s tangible net worth is not thereby reduced,
and as long as no Event of Default is occurring prior thereto or arises as a result therefrom.
7.4 Indebtedness. Create, incur, assume, or be liable for any Indebtedness, or permit
any Subsidiary to do so, other than Permitted Indebtedness.
7.5 Encumbrance. Create, incur, allow, or suffer any Lien on any of its property, or
assign or convey any right to receive income, including the sale of any Accounts, or permit any of
its Subsidiaries to do so, except for Permitted Liens, or permit any Collateral not to be subject
to the first priority security interest granted herein, or enter into any agreement, document,
instrument or other arrangement (except with or in favor of Agent) with any Person which directly
or indirectly prohibits or has the effect of prohibiting Borrower or any Subsidiary from assigning,
mortgaging, pledging, granting a
security interest in or upon, or encumbering any of Borrower’s or any Subsidiary’s
Intellectual Property, except as is otherwise permitted in Section 7.1 hereof and the definition of
“Permitted Liens” herein.
14
7.6 Maintenance of Collateral Accounts. Maintain any Collateral Account except
pursuant to the terms of Section 6.6(b) hereof.
7.7 Distributions; Investments. (a) Pay any dividends (other than dividends payable
solely in common stock) or make any distribution or payment on or redeem, retire or purchase any
capital stock (other than repurchases pursuant to the terms of employee stock purchase plans,
employee restricted stock agreements or similar plans), or (b) directly or indirectly make any
Investment other than Permitted Investments, or permit any of its Subsidiaries to do so.
7.8 Transactions with Affiliates. Directly or indirectly enter into or permit to
exist any material transaction with any Affiliate of Borrower, except for transactions that are in
the ordinary course of Borrower’s business, upon fair and reasonable terms that are no less
favorable to Borrower than would be obtained in an arm’s length transaction with a non-affiliated
Person.
7.9 Subordinated Debt. (a) Make or permit any payment on any Subordinated Debt,
except under the terms of the subordination, intercreditor, or other similar agreement to which
such Subordinated Debt is subject, or (b) amend any provision in any document relating to the
Subordinated Debt which would increase the amount thereof or adversely affect the subordination
thereof to Obligations owed to the Lenders.
7.10 Compliance. Become an “investment company” or a company controlled by an
“investment company”, under the Investment Company Act of 1940, as amended or undertake as one of
its important activities extending credit to purchase or carry margin stock (as defined in
Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any
Credit Extension for that purpose; fail to meet the minimum funding requirements of ERISA, permit a
Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; fail to comply with the
Federal Fair Labor Standards Act or violate any other Law or regulation, if the violation could
reasonably be expected to have a material adverse effect on Borrower’s business, or permit any of
its Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation in,
permit partial or complete termination of, or permit the occurrence of any other event with respect
to, any present pension, profit sharing and deferred compensation plan which could reasonably be
expected to result in any liability of Borrower, including any liability to the Pension Benefit
Guaranty Corporation or its successors or any other governmental agency.
7.11 Compliance with Anti-Terrorism Laws. Agent hereby notifies Borrower that
pursuant to the requirements of Anti-Terrorism Laws, and Agent’s policies and practices, Agent is
required to obtain, verify and record certain information and documentation that identifies
Borrower and its principals, which information includes the name and address of Borrower and its
principals and such other information that will allow Agent to identify such party in accordance
with Anti-Terrorism Laws. Borrower will not, nor will Borrower permit any Subsidiary or Affiliate
to, directly or indirectly, knowingly enter into any documents, instruments, agreements or
contracts with any Person listed on the OFAC Lists. Borrower shall immediately notify Agent if
Borrower has knowledge that Borrower or any Subsidiary or Affiliate is listed on the OFAC Lists or
(a) is convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned and
held over on charges involving money laundering or predicate crimes to money laundering. Borrower
will not, nor will Borrower permit any Subsidiary or Affiliate to, directly or indirectly, (i)
conduct any business or engage in any transaction or dealing with any Blocked Person, including,
without limitation, the making or receiving of any contribution of funds, goods or services to or
for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any transaction
relating to, any property or interests in property blocked pursuant to Executive Order No. 13224,
any similar executive order or other Anti-Terrorism Law, or (iii) engage in or conspire to engage
in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to
violate, any of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism
Law.
8 EVENTS OF DEFAULT
Any one of the following shall constitute an event of default (an “Event of Default”) under
this Agreement:
8.1 Payment Default. Borrower fails to (a) make any payment of principal or interest
on any Credit Extension on its due date, or (b) pay any other Obligations within three (3) Business
Days after such Obligations are due and payable
(which three (3) Business Day grace period
shall not apply to payments due on the
Maturity Date or the date of acceleration
pursuant to Section 9.1 (a) hereof).
During the cure period, the failure to
cure the payment default is not an Event
of Default (but no Credit Extension will
be made during the cure period);
15
8.2 Covenant Default.
(a) Borrower fails or neglects to perform any obligation in Sections 6.1(c), 6.2, 6.4, 6.5,
6.6, 6.7, 6.10, or 6.11 or violates any covenant in Section 7; or
(b) Borrower or any of its Subsidiaries fails or neglects to perform, keep, or observe any
other term, provision, condition, covenant or agreement contained in this Agreement or any Loan
Documents, and as to any default (other than those specified in this Section 8) under such other
term, provision, condition, covenant or agreement that can be cured, has failed to cure the default
within ten (10) days after the occurrence thereof; provided, however, that if the default cannot by
its nature be cured within the ten (10) day period or cannot after diligent attempts by Borrower be
cured within such ten (10) day period, and such default is likely to be cured within a reasonable
time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30)
days) to attempt to cure such default, and within such reasonable time period the failure to cure
the default shall not be deemed an Event of Default (but no Credit Extensions shall be made during
such cure period). Grace periods provided under this Section shall not apply, among other things,
to financial covenants or any other covenants set forth in subsection (a) above;
8.3 Material Adverse Change. A Material Adverse Change occurs;
8.4 Attachment; Levy; Restraint on Business.
(a) (i) The service of process seeking to attach, by trustee or similar process, any funds of
Borrower or of any entity under control of Borrower (including a Subsidiary) on deposit with the
Lenders or any Lender Affiliate, or (ii) a notice of lien, levy, or assessment is filed against any
of Borrower’s assets by any government agency, and the same under subclauses (i) and (ii) hereof
are not, within ten (10) days after the occurrence thereof, discharged or stayed (whether through
the posting of a bond or otherwise); provided, however, no Credit Extensions shall be made during
any ten (10) day cure period; and
(b) (i) any material portion of Borrower’s assets is attached, seized, levied on, or comes
into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents
Borrower from conducting any part of its business;
8.5 Insolvency. (a) Borrower is unable to pay its debts (including trade debts) as
they become due or otherwise becomes insolvent; (b) Borrower begins an Insolvency Proceeding; or
(c) an Insolvency Proceeding is begun against Borrower and not dismissed or stayed within
forty-five (45) days (but no Credit Extensions shall be made while any of the conditions described
in clause (a) exist and/or until any Insolvency Proceeding is dismissed);
8.6 Other Agreements. There is a default in any agreement to which Borrower is a
party with a third party or parties resulting in a right by such third party or parties, whether or
not exercised, to accelerate the maturity of any Indebtedness in an amount in excess of Seventy
Five Thousand Dollars ($75,000) or that could have a material adverse effect on Borrower’s
business;
8.7 Judgments. One or more judgments, orders, or decrees for the payment of money in
an amount, individually or in the aggregate, of at least Fifty Thousand Dollars ($50,000) (not
covered by independent third-party insurance as to which liability has been accepted by such
insurance carrier) shall be rendered against Borrower and shall remain unsatisfied, unvacated, or
unstayed for a period of ten (10) days after the entry thereof (provided that no Credit Extensions
will be made prior to the satisfaction, vacation, or stay of such judgment, order or decree);
8.8 Misrepresentations. Borrower or any Person acting for Borrower makes any
representation, warranty, or other statement now or later in this Agreement, any Loan Document or
in any writing delivered to Agent and/or the Lenders
or to induce Agent and/or the Lenders to enter this Agreement or any Loan Document, and such
representation, warranty, or other statement is incorrect in any material respect when made;
16
8.9 Subordinated Debt. A default or breach occurs under any agreement between
Borrower and any creditor of Borrower that signed a subordination, intercreditor, or other similar
agreement with Agent or the Lenders, or any creditor that has signed such an agreement with Agent
or the Lenders breaches any terms of such agreement;
8.10 Governmental Approvals. Any Governmental Approval shall have been (a) revoked,
rescinded, suspended, modified in an adverse manner or not renewed in the ordinary course for a
full term or (b) subject to any decision by a Governmental Authority that designates a hearing with
respect to any applications for renewal of any of such Governmental Approval or that could result
in the Governmental Authority taking any of the actions described in clause (a) above, and such
decision or such revocation, rescission, suspension, modification or non-renewal (i) has, or could
reasonably be expected to have, a Material Adverse Change, or (ii) adversely affects the legal
qualifications of Borrower or any of its Subsidiaries to hold such Governmental Approval in any
applicable jurisdiction and such revocation, rescission, suspension, modification or non-renewal
could reasonably be expected to affect the status of or legal qualifications of Borrower or any of
its Subsidiaries to hold any Governmental Approval in any other jurisdiction;
8.11 Criminal Proceeding. The institution by any Governmental Authority of criminal
proceedings against Borrower;
8.12 Lien Priority. Except as permitted by Agent, any Lien created hereunder or by
any other Loan Document shall at any time fail to constitute a valid and perfected Lien on all of
the Collateral purported to be secured thereby, subject to no prior or equal Lien; or
8.13 Withdrawals, Recalls, Adverse Test Results and Other Matters. (a) The
institution of any proceeding by FDA or similar Governmental Authority to order the withdrawal of
any Product or Product category from the market or to enjoin Borrower or any representative of
Borrower from manufacturing, marketing, selling or distributing any Product or Product category,
which, in each case, could cause a Material Adverse Change (b) the institution of any action or
proceeding by any DEA, FDA, or any other Governmental Authority to revoke, suspend, reject,
withdraw, limit, or restrict any Required Permit held by Borrower or any representative of
Borrower, which, in each case, could cause a Material Adverse Change, (c) the commencement of any
enforcement action against Borrower by DEA, FDA, or any other Governmental Authority, (d) the
recall of any Products from the market, the voluntary withdrawal of any Products from the market,
or actions to discontinue the sale of any Products, which, in each case, could cause a Material
Adverse Change, or (e) the occurrence of adverse test results in connection with a Product which
could cause a Material Adverse Change.
9 RIGHTS AND REMEDIES
9.1 Rights and Remedies.
Upon the occurrence and during the continuance of an Event of Default, Agent may, and at the
written direction of any Lender shall, without notice or demand, do any or all of the following:
(i) deliver notice of the Event of Default to Borrower, (ii) by notice to Borrower declare all
Obligations immediately due and payable (but if an Event of Default described in Section 8.5 occurs
all Obligations shall be immediately due and payable without any action by Agent or the Lenders) or
(iii) by notice to Borrower suspend or terminate the obligations, if any, of the Lenders to
advance money or extend credit for Borrower’s benefit under this Agreement or under any other
agreement between Borrower and Agent and/or the Lenders (but if an Event of Default described in
Section 8.5 occurs all obligations, if any, of the Lenders to advance money or extend credit for
Borrower’s benefit under this Agreement or under any other agreement between Borrower and Agent
and/or the Lenders shall be immediately terminated without any action by Agent or the Lenders).
(b) Without limiting the rights of Agent and the Lenders set forth in Section 9.1(a) above,
upon the occurrence and during the continuance of an Event of Default Agent shall have the right,
at the written direction of the Required Lenders, without notice or demand, to do any or all of the
following:
(i) foreclose upon and/or sell or otherwise liquidate, the Collateral;
17
(ii) apply to the Obligations any (a) balances and deposits of Borrower that Agent or any
Lender holds or controls, or (b) any amount held or controlled by Agent or any Lender owing to or
for the credit or the account of Borrower; and/or
(iii) commence and prosecute an Insolvency Proceeding or consent to Borrower commencing any
Insolvency Proceeding.
(c) Without limiting the rights of Agent and the Lenders set forth in Sections 9.1(a) and (b)
above, upon the occurrence and during the continuance of an Event of Default Agent shall have the
right, without notice or demand, to do any or all of the following:
(i) settle or adjust disputes and claims directly with Account Debtors for amounts on terms
and in any order that Agent considers advisable, notify any Person owing Borrower money of Agent’s
security interest in such funds, and verify the amount of such account;
(ii) make any payments and do any acts it considers necessary or reasonable to protect the
Collateral and/or its security interest in the Collateral. Borrower shall assemble the Collateral
if Agent requests and make it available as Agent designates. Agent may enter premises where the
Collateral is located, take and maintain possession of any part of the Collateral, and pay,
purchase, contest, or compromise any Lien which appears to be prior or superior to its security
interest and pay all expenses incurred. Borrower grants Agent a license to enter and occupy any of
its premises, without charge, to exercise any of Agent’s rights or remedies;
(iii) ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, and/or
advertise for sale, the Collateral. Agent is hereby granted a non-exclusive, royalty-free license
or other right to use, without charge, Borrower’s labels, patents, copyrights, mask works, rights
of use of any name, trade secrets, trade names, trademarks, service marks, and advertising matter,
or any similar property as it pertains to the Collateral, in completing production of, advertising
for sale, and selling any Collateral and, in connection with Agent’s exercise of its rights under
this Section 9.1, Borrower’s rights under all licenses and all franchise agreements inure to Agent
for the benefit of the Lenders;
(iv) place a “hold” on any account maintained with Agent or the Lenders and/or deliver a
notice of exclusive control, any entitlement order, or other directions or instructions pursuant to
any Control Agreement or similar agreements providing control of any Collateral;
(v) demand and receive possession of Borrower’s Books; and
(vi) Subject to clauses 9.1(a) and (b), exercise all rights and remedies available to Agent
under the Loan Documents or at law or equity, including all remedies provided under the Code
(including disposal of the Collateral pursuant to the terms thereof).
Notwithstanding any provision of this Section 9.1 to the contrary, upon the occurrence of any Event
of Default, Agent shall have the right to exercise any and all remedies referenced in this Section
9.1 without the written consent of Required Lenders following the occurrence of an Exigent
Circumstance. As used in the immediately preceding sentence, “Exigent Circumstance” means any
event or circumstance that, in the reasonable judgment of Agent, imminently threatens the ability
of Agent to realize upon all or any material portion of the Collateral, such as, without
limitation, fraudulent removal, concealment, or abscondment thereof, destruction or material waste
thereof, or failure of Borrower after reasonable demand to maintain or reinstate adequate casualty
insurance coverage, or which, in the judgment of Agent, could result in a material diminution in
value of the Collateral.
18
9.2 Power of Attorney. Borrower hereby irrevocably appoints Agent as its lawful
attorney-in-fact, exercisable upon the occurrence and during the continuance of an Event of
Default, to: (a) endorse Borrower’s name on any checks or other forms of payment or security; (b)
sign Borrower’s name on any invoice or xxxx of lading for any Account or drafts against Account
Debtors; (c) settle and adjust disputes and claims about the Accounts directly with Account
Debtors, for amounts and on terms Agent determines reasonable; (d) make, settle, and adjust all
claims under Borrower’s insurance policies; (e) pay, contest or settle any Lien, charge,
encumbrance, security interest, and adverse claim in or to the Collateral, or any judgment based
thereon, or otherwise take any action to terminate or discharge the same; and (f) transfer the
Collateral
into the name of Agent or a third party as the Code permits. Borrower hereby appoints Agent
as its lawful attorney-in-fact to sign Borrower’s name on any documents necessary to perfect or
continue the perfection of Agent’s security interest in the Collateral regardless of whether an
Event of Default has occurred until all Obligations have been satisfied in full and Agent and the
Lenders are under no further obligation to make Credit Extensions hereunder. Agent’s foregoing
appointment as Borrower’s attorney in fact, and all of Agent’s rights and powers, coupled with an
interest, are irrevocable until all Obligations have been fully repaid and performed and Agent’s
and the Lenders’ obligation to provide Credit Extensions terminates.
9.3 Protective Payments. If Borrower fails to obtain the insurance called for by
Section 6.5 or fails to pay any premium thereon or fails to pay any other amount which Borrower is
obligated to pay under this Agreement or any other Loan Document, Agent may obtain such insurance
or make such payment, and all amounts so paid by Agent are Lenders’ Expenses and immediately due
and payable, bearing interest at the then highest applicable rate, and secured by the Collateral.
Agent will make reasonable efforts to provide Borrower with notice of Agent obtaining such
insurance at the time it is obtained or within a reasonable time thereafter. No such payments by
Agent are deemed an agreement to make similar payments in the future or Agent’s waiver of any Event
of Default.
9.4 Application of Payments and Proceeds. Notwithstanding anything to the contrary
contained in this Agreement, upon the occurrence and during the continuance of an Event of Default,
(a) Borrower irrevocably waives the right to direct the application of any and all payments at any
time or times thereafter received by Agent from or on behalf of Borrower of all or any part of the
Obligations, and, as between Borrower on the one hand and Agent and the Lenders on the other, Agent
shall have the continuing and exclusive right to apply and to reapply any and all payments received
against the Obligations in such manner as Agent may deem advisable notwithstanding any previous
application by Agent, and (b) the proceeds of any sale of, or other realization upon all or any
part of the Collateral shall be applied: first, to Lenders Expenses; second, to accrued and unpaid
interest on the Obligations (including any interest which, but for the provisions of the United
States Bankruptcy Code, would have accrued on such amounts); third, to the principal amount of the
Obligations outstanding; and fourth, to any other indebtedness or obligations of Borrower owing to
Agent or any Lender under the Loan Documents. Any balance remaining shall be delivered to Borrower
or to whoever may be lawfully entitled to receive such balance or as a court of competent
jurisdiction may direct. In carrying out the foregoing, (x) amounts received shall be applied in
the numerical order provided until exhausted prior to the application to the next succeeding
category, and (y) each of the Persons entitled to receive a payment in any particular category
shall receive an amount equal to its pro rata share of amounts available to be applied pursuant
thereto for such category. Any reference in this Agreement to an allocation between or sharing by
the Lenders of any right, interest or obligation “ratably,” “proportionally” or in similar terms
shall refer to Pro Rata Share unless expressly provided otherwise. Agent, or if applicable, each
Lender, shall promptly remit to the other Lenders such sums as may be necessary to ensure the
ratable repayment of each Lender’s portion of any Term Loan and the ratable distribution of
interest, fees and reimbursements paid or made by Borrower. Notwithstanding the foregoing, a
Lender receiving a scheduled payment shall not be responsible for determining whether the other
Lenders also received their scheduled payment on such date; provided, however, if it is later
determined that a Lender received more than its ratable share of scheduled payments made on any
date or dates, then such Lender shall remit to Agent or other Lenders such sums as may be necessary
to ensure the ratable payment of such scheduled payments, as instructed by Agent. Any payment or
distribution of any kind or character, whether in cash, properties or securities, shall be received
by a Lender in excess of its ratable share, then the portion of such payment or distribution in
excess of such Lender’s ratable share shall be received by such Lender in trust for and shall be
promptly paid over to the other Lender for application to the payments of amounts due on the other
Lender’s claims. To the extent any payment for the account of Borrower is required to be returned
as a voidable transfer or otherwise, the Lenders shall contribute to one another as is necessary to
ensure that such return of payment is on a pro rata basis. If any Lender shall obtain possession
of any Collateral, it shall hold such Collateral for itself and as agent and bailee for Agent and
other Lenders for purposes of perfecting Agent’s security interest therein. Notwithstanding
anything to the contrary herein, any warrants issued to the Lenders by Borrower, the stock issuable
thereunder, any equity securities purchased by Lenders, any amounts paid thereunder, any dividends,
and any other rights in connection therewith shall not be subject to the terms and conditions of
this Agreement. Nothing herein shall affect any Lender’s rights under any such warrants, stock, or
other equity securities to administer, manage, transfer, assign, or exercise such warrants, stock,
or other equity securities for its own account.
19
9.5 Liability for Collateral. So long as Agent and the Lenders comply with reasonable
banking practices regarding the safekeeping of the Collateral in the possession or under the
control of Agent and the Lenders, Agent and the Lenders shall not be liable or responsible for: (a)
the safekeeping of the Collateral; (b) any loss or damage to the Collateral;
(c) any diminution in the value of the Collateral; or (d) any act or default of any carrier,
warehouseman, bailee, or other Person. Borrower bears all risk of loss, damage or destruction of
the Collateral.
9.6 No Waiver; Remedies Cumulative. Agent’s failure, at any time or times, to require
strict performance by Borrower of any provision of this Agreement or any other Loan Document shall
not waive, affect, or diminish any right of Agent thereafter to demand strict performance and
compliance herewith or therewith. No waiver hereunder shall be effective unless signed by Agent
and then is only effective for the specific instance and purpose for which it is given. Agent’s
rights and remedies under this Agreement and the other Loan Documents are cumulative. Agent has
all rights and remedies provided under the Code, by Law, or in equity. Agent’s exercise of one
right or remedy is not an election, and Agent’s waiver of any Event of Default is not a continuing
waiver. Agent’s delay in exercising any remedy is not a waiver, election, or acquiescence.
9.7 Demand Waiver. Borrower waives, to the fullest extent permitted by law, demand,
notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment
at maturity, release, compromise, settlement, extension, or renewal of accounts, documents,
instruments, chattel paper, and guarantees held by Agent on which Borrower is liable.
10 NOTICES
All notices, consents, requests, approvals, demands, or other communication (collectively,
“Communication”) by any party to this Agreement or any other Loan Document must be in writing and
shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual
receipt and three (3) Business Days after deposit in the U.S. mail, first class, registered or
certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when
sent by electronic mail (if an email address is specified herein) or facsimile transmission; (c)
one (1) Business Day after deposit with a reputable overnight courier with all charges prepaid; or
(d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to
be notified and sent to the address, facsimile number, or email address indicated below. Any of
Agent, Lender or Borrower may change its mailing or electronic mail address or facsimile number by
giving the other party written notice thereof in accordance with the terms of this Section 10.
If to Borrower:
c/o Biolase Technology, Inc.
0 Xxxxxxxx
Xxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxx X. Xxxxxx
Chief Executive Officer
0 Xxxxxxxx
Xxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxx X. Xxxxxx
Chief Executive Officer
If to Agent or Lenders:
MidCap Financial, LLC
0000 Xxx Xxxxxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, Xxxxxxxx 00000
Attention: Portfolio Management- Life Sciences
0000 Xxx Xxxxxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, Xxxxxxxx 00000
Attention: Portfolio Management- Life Sciences
with a copy to:
Xxxxxx & Xxxxxxxxxx LLP
Xxxxx Xxxxxx Xxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Attention: Xxxx X. Xxxxxx, Esquire
Xxxxx Xxxxxx Xxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Attention: Xxxx X. Xxxxxx, Esquire
20
11 CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER
Maryland Law governs the Loan Documents without regard to principles of conflicts of law.
Borrower, Lenders and Agent each submit to the exclusive jurisdiction of the State and Federal
courts in Maryland. NOTWITHSTANDING THE FOREGOING, AGENT AND LENDERS SHALL HAVE THE RIGHT TO BRING
ANY ACTION OR PROCEEDING AGAINST BORROWER OR ITS PROPERTY IN THE COURTS OF ANY OTHER JURISDICTION
WHICH AGENT
AND LENDERS (IN ACCORDANCE WITH THE PROVISIONS OF SECTION 9.1) DEEM NECESSARY OR APPROPRIATE
TO REALIZE ON THE COLLATERAL OR TO OTHERWISE ENFORCE AGENT’S AND LENDERS’ RIGHTS AGAINST BORROWER
OR ITS PROPERTY. Borrower expressly submits and consents in advance to such jurisdiction in any
action or suit commenced in any such court, and Borrower hereby waives any objection that it may
have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby
consents to the granting of such legal or equitable relief as is deemed appropriate by such court.
Borrower hereby waives personal service of the summons, complaints, and other process issued in
such action or suit and agrees that service of such summons, complaints, and other process may be
made by registered or certified mail addressed to Borrower at the address set forth in Section 10
of this Agreement and that service so made shall be deemed completed upon the earlier to occur of
Borrower’s actual receipt thereof or three (3) days after deposit in the U.S. mails, proper postage
prepaid.
TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, BORROWER, AGENT AND LENDERS
EACH WAIVE THEIR RIGHT TO A JURY TRIAL OF
ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF
OR BASED UPON THIS AGREEMENT, THE LOAN
DOCUMENTS OR ANY CONTEMPLATED TRANSACTION,
INCLUDING CONTRACT, TORT, BREACH OF DUTY
AND ALL OTHER CLAIMS. THIS WAIVER IS A
MATERIAL INDUCEMENT FOR BOTH PARTIES TO
ENTER INTO THIS AGREEMENT. EACH PARTY HAS REVIEWED THIS WAIVER WITH ITS COUNSEL.
Borrower, Agent and each Lender agree that
each Term Loan (including those made on the
Effective Date) shall be deemed to be made
in, and the transactions contemplated
hereunder and in any other Loan Document
(other than the Warrants) shall be deemed
to have been performed in, the State of
Maryland.
12 GENERAL PROVISIONS
12.1 Successors and Assigns. This Agreement binds and is for the benefit of the
successors and permitted assigns of each party. Borrower may not assign this Agreement or any
rights or obligations under it without Agent’s prior written consent (which may be granted or
withheld in Agent’s discretion, subject to Section 12.11). The Lenders have the right, without the
consent of or notice to Borrower, to sell, transfer, assign, negotiate, or grant participation in
all or any part of, or any interest in, the Lenders’ obligations, rights, and benefits under this
Agreement and the other Loan Documents provided, however, that any such sale, assignment,
negotiation or grant of a participation by any Lender (other than a sale or assignment to an
Eligible Assignee) of its obligations, rights, and benefits under this Agreement and the other Loan
Documents shall require the prior written consent of the Required Lenders (such approved assignee,
an “Approved Lender”). Borrower and Agent shall be entitled to continue to deal solely and
directly with such Lender in connection with the interests so assigned until Agent shall have
received and accepted an effective Assignment Agreement executed, delivered and fully completed by
the applicable parties thereto, and shall have received such other information regarding such
Eligible Assignee or Approved Lender as Agent reasonably shall require.
12.2 Indemnification.
(a) Borrower agrees to indemnify, defend and hold Agent and the Lenders and their respective
directors, officers, employees, agents, attorneys, or any other Person affiliated with or
representing Agent or the Lenders (each, an “Indemnified Person”) harmless against: (a) all
obligations, demands, claims, and liabilities (collectively, “Claims”) asserted by any other party
in connection with the transactions contemplated by the Loan Documents; and (b) all losses or
Lenders’ Expenses incurred, or paid by Indemnified Person from, following, or arising from
transactions between Agent, and/or the Lenders and Borrower (including reasonable attorneys’ fees
and expenses), except for Claims and/or losses directly caused by such Indemnified Person’s gross
negligence or willful misconduct (collectively, the “Indemnified Liabilities”).
(b) Borrower hereby further indemnifies, defends and holds each Indemnified Person harmless
from and against any and all liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, claims, costs, expenses and disbursements of any kind or nature whatsoever
(including the fees and disbursements of counsel for such Indemnitee), except to the extent
directly caused by such Indemnified Person’s gross negligence or willful misconduct, in connection
with any investigative, response, remedial, administrative or judicial matter or proceeding,
whether or not such Indemnified Person shall be designated a party thereto and including any such
proceeding initiated by or on behalf of Borrower, and the reasonable expenses of investigation by
engineers,
environmental consultants and similar technical personnel and any commission, fee or
compensation claimed by any broker (other than any broker retained by Agent or Lenders) asserting
any right to payment for the transactions contemplated hereby which may be imposed on, incurred by
or asserted against such Indemnified Person as a result of or in connection with the transactions
contemplated hereby and the use or intended use of the proceeds of the loan proceeds.
21
(c) To the extent that the undertaking set forth in this Section 12.2 may be unenforceable,
Borrower shall contribute the maximum portion which it is permitted to pay and satisfy under
applicable law to the payment and satisfaction of all such indemnified liabilities incurred by the
Indemnitees or any of them.
12.3 Time of Essence. Time is of the essence for the performance of all Obligations
in this Agreement.
12.4 Severability of Provisions. Each provision of this Agreement is severable from
every other provision in determining the enforceability of any provision.
12.5 Correction of Loan Documents. Agent and the Lenders may correct patent errors
and fill in any blanks in this Agreement and the other Loan Documents consistent with the agreement
of the parties.
12.6 Integration. This Agreement and the Loan Documents represent the entire
agreement about this subject matter and supersede prior negotiations or agreements. All prior
agreements, understandings, representations, warranties, and negotiations between the parties about
the subject matter of this Agreement and the Loan Documents merge into this Agreement and the Loan
Documents.
12.7 Counterparts. This Agreement may be executed in any number of counterparts and
by different parties on separate counterparts, each of which, when executed and delivered, is an
original, and all taken together, constitute one Agreement.
12.8 Survival. All covenants, representations and warranties made in this Agreement
continue in full force until this Agreement has terminated pursuant to its terms and all
Obligations (other than inchoate indemnity obligations and any other obligations which, by their
terms, are to survive the termination of this Agreement) have been satisfied. The obligation of
Borrower in Section 12.2 to indemnify each Lender and Agent shall survive until the statute of
limitations with respect to such claim or cause of action shall have run.
12.9 Confidentiality. In handling any confidential information of Borrower, the
Lenders and Agent shall exercise the same degree of care that it exercises for its own proprietary
information, but disclosure of information may be made: (a) to the Lenders’ and Agent’s
Subsidiaries or Affiliates; (b) to prospective transferees or purchasers of any interest in the
Credit Extensions (provided, however, the Lenders and Agent shall use commercially reasonable
efforts to obtain such prospective transferee’s or purchaser’s agreement to the terms of this
provision); (c) as required by Law, regulation, subpoena, or other order; (d) to regulators or as
otherwise required in connection with an examination or audit; (e) as Agent considers appropriate
in exercising remedies under the Loan Documents; and (f) to third party service providers of the
Lenders and/or Agent so long as such service providers have executed a confidentiality agreement
with the Lenders and Agent with terms no less restrictive than those contained herein. Confidential
information does not include information that either: (i) is in the public domain or in the
Lenders’ and/or Agent’s possession when disclosed to the Lenders and/or Agent, or becomes part of
the public domain after disclosure to the Lenders and/or Agent; or (ii) is disclosed to the Lenders
and/or Agent by a third party, if the Lenders and/or Agent does not know that the third party is
prohibited from disclosing the information. Lenders and/or Agent may use confidential information
for any purpose, including, without limitation, for the development of client databases, reporting
purposes, and market analysis, so long as Lenders and/or Agent do not disclose Borrower’s identity
or the identity of any person associated with Borrower unless otherwise expressly permitted by this
Agreement. The provisions of the immediately preceding sentence shall survive the termination of
this Agreement. The agreements provided under this Section 12.9 supersede all prior agreements,
understanding, representations, warranties, and negotiations between the parties about the subject
matter of this Section 12.9. In respect of confidential information provided by Borrower to Agent
and Lenders hereunder and Borrower’s securities Agent and Lenders agree to comply with applicable
securities laws which prohibit trading in securities based upon material non-public information.
22
12.10 Right of Set Off. Borrower hereby grants to Agent and to each Lender, a lien,
security interest and right of set off as security for all Obligations to Agent and each Lender
hereunder, whether now existing or hereafter arising upon and against all deposits, credits,
collateral and property, now or hereafter in the possession, custody, safekeeping or control of
Agent or the Lenders or any entity under the control of Agent or the Lenders (including a Agent
affiliate) or in transit to any of them. At any time after the occurrence and during the
continuance of an Event of Default, without demand or notice, Agent or the Lenders may set off the
same or any part thereof and apply the same to any liability or obligation of Borrower even though
unmatured and regardless of the adequacy of any other collateral securing the Obligations. ANY AND
ALL RIGHTS TO REQUIRE AGENT TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL
WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH
DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY
WAIVED.
12.11 Amendments.
(a) No amendment, modification, termination or waiver of any provision of this Agreement or
any other Loan Document, no approval or consent thereunder, or any consent to any departure by
Borrower therefrom, shall in any event be effective unless the same shall be in writing and signed
by Borrower, Agent and the Required Lenders provided that
(i) no such amendment, waiver or other modification that would have the effect of increasing
or reducing a Lender’s Term Loan Commitment or Commitment Percentage shall be effective as to such
Lender without such Lender’s written consent;
(ii) no such amendment, waiver or modification that would affect the rights and duties of
Agent shall be effective without Agent’s written consent or signature;
(iii) no such amendment, waiver or other modification shall, unless signed by all the Lenders
directly affected thereby, (A) reduce the principal of, rate of interest on or any fees with
respect to any Term Loan or forgive any principal, interest (other than default interest) or fees
(other than late charges) with respect to any Term Loan (B) postpone the date fixed for, or waive,
any payment of principal of any Term Loan or of interest on any Term Loan (other than default
interest) or any fees provided for hereunder (other than late charges or for any termination of any
commitment); (C) change the definition of the term “Required Lenders” or the percentage of Lenders
which shall be required for Lenders to take any action hereunder; (D) release all or substantially
all or any material portion of the Collateral, authorize Borrower to sell or otherwise dispose of
all or substantially all or any material portion of the Collateral or release any Guarantor of all
or any portion of the Obligations or its guaranty obligations with respect thereto, except, in each
case with respect to this clause (D), as otherwise may be expressly permitted under this Agreement
or the other Loan Documents (including in connection with any disposition permitted hereunder); (E)
amend, waive or otherwise modify this Section 12.11 or the definitions of the terms used in this
Section 12.11 insofar as the definitions affect the substance of this Section 12.11; (F) consent to
the assignment, delegation or other transfer by any Borrower or any Guarantor of any of its rights
and obligations under any Loan Document or release Borrower or any Guarantor of its payment
obligations under any Loan Document, except, in each case with respect to this clause (F),
pursuant to a merger or consolidation permitted pursuant to this Agreement; (G) amend any of the
provisions of Section 9.4 or amend any of the definitions Pro Rata Share, Term Loan Commitment,
Commitment Percentage or that provide for the Lenders to receive their Pro Rata Shares of any fees,
payments, setoffs or proceeds of Collateral hereunder; (H) subordinate the Liens granted in favor
of Agent securing the Obligations; or (I) amend any of the provisions of Section 12.10. It is
hereby understood and agreed that all Lenders shall be deemed directly affected by an amendment,
waiver or other modification of the type described in the preceding clauses (C), (D), (E), (F), (G)
and (H) of the preceding sentence;
(iv) the provisions of the foregoing clauses (i), (ii) and (iii) are subject to the provisions
of any interlender or agency agreement among the Lenders and Agent pursuant to which any Lender may
agree to give its consent in connection with any amendment, waiver or modification of the Loan
Documents only in the event of the unanimous agreement of all Lenders.
(b) Other than as expressly provided for in Section 12.11(a)(i)-(iii), Agent may, if requested
by the Required Lenders, from time to time designate covenants in this Agreement less restrictive
by notification to a
representative of the Borrower.
23
12.12 Publicity. Borrower will not directly or indirectly publish, disclose or
otherwise use in any public disclosure, advertising material, promotional material, press release
or interview, any reference to the name, logo or any trademark of Agent or any Lender or any of
their Affiliates or any reference to this Agreement or the financing evidenced hereby, in any case
except as required by applicable Law, subpoena or judicial or similar order, in which case Borrower
shall endeavor to give Agent prior written notice of such publication or other disclosure. Each
Lender and Borrower hereby authorizes each Lender to publish the name of such Lender and Borrower,
the existence of the financing arrangements referenced under this Agreement, the primary purpose
and/or structure of those arrangements, the amount of credit extended under each facility, the
title and role of each party to this Agreement, and the total amount of the financing evidenced
hereby in any “tombstone”, comparable advertisement or press release which such Lender elects to
submit for publication. In addition, each Lender and Borrower agrees that each Lender may provide
lending industry trade organizations with information necessary and customary for inclusion in
league table measurements after the Effective Date. With respect to any of the foregoing, such
authorization shall be subject to such Lender providing Borrower and the other Lenders with an
opportunity to review and confer with such Lender regarding, and approve, the contents of any such
tombstone, advertisement or information, as applicable, prior to its initial submission for
publication, but subsequent publications of the same tombstone, advertisement or information shall
not require Borrower’s approval.
12.13 No Strict Construction. The parties hereto have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted jointly by the parties
hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provisions of this Agreement.
13 AGENT
13.1 Appointment and Authorization of Agent. Each Lender hereby irrevocably appoints,
designates and authorizes Agent to take such action on its behalf under the provisions of this
Agreement and each other Loan Document and to exercise such powers and perform such duties as are
expressly delegated to it by the terms of this Agreement or any other Loan Document, together with
such powers as are reasonably incidental thereto. Notwithstanding any provision to the contrary
contained elsewhere herein or in any other Loan Document, Agent shall not have any duties or
responsibilities, except those expressly set forth herein, nor shall Agent have or be deemed to
have any fiduciary relationship with any Lender or participant, and no implied covenants,
functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement
or any other Loan Document or otherwise exist against Agent. Without limiting the generality of the
foregoing sentence, the use of the term “agent” herein and in the other Loan Documents with
reference to Agent is not intended to connote any fiduciary or other implied (or express)
obligations arising under agency doctrine of any applicable Law. Instead, such term is used merely
as a matter of market custom, and is intended to create or reflect only an administrative
relationship between independent contracting parties.
13.2 Delegation of Duties. Agent may execute any of its duties under this Agreement or
any other Loan Document by or through its, or its Affiliates’, agents, employees or
attorneys-in-fact and shall be entitled to obtain and rely upon the advice of counsel and other
consultants or experts concerning all matters pertaining to such duties. Agent shall not be
responsible for the negligence or misconduct of any agent or attorney-in-fact that it selects in
the absence of gross negligence or willful misconduct.
13.3 Liability of Agent. Except as otherwise provided herein, no Agent-Related Person
shall (a) be liable for any action taken or omitted to be taken by any of them under or in
connection with this Agreement or any other Loan Document or the transactions contemplated hereby
(except for its own gross negligence or willful misconduct in connection with its duties expressly
set forth herein), or (b) be responsible in any manner to any Lender or participant for any
recital, statement, representation or warranty made by Borrower or any officer thereof, contained
herein or in any other Loan Document, or in any certificate, report, statement or other document
referred to or provided for in, or received by Agent under or in connection with, this Agreement or
any other Loan Document, or the validity, effectiveness, genuineness, enforceability or sufficiency
of this Agreement or any other Loan Document, or for any failure of Borrower or any other party to
any Loan Document to perform its obligations hereunder or thereunder. No Agent-Related Person shall
be under any obligation to any Lender or participant to ascertain or to inquire as to the
observance or performance of any of the agreements contained in, or conditions of, this Agreement
or any other Loan Document, or to inspect the properties, books or records of Borrower or any
Affiliate thereof.
24
13.4 Reliance by Agent. Agent shall be entitled to rely, and shall be fully protected
in relying, upon any writing, communication, signature, resolution, representation, notice,
consent, certificate, affidavit, letter, telegram, facsimile, telex or telephone message,
electronic mail message, statement or other document or conversation believed by it to be genuine
and correct and to have been signed, sent or made by the proper Person or Persons, and upon advice
and statements of legal counsel (including counsel to Borrower), independent accountants and other
experts selected by Agent. Agent shall be fully justified in failing or refusing to take any action
under any Loan Document unless it shall first receive such advice or concurrence of all Lenders as
it deems appropriate and, if it so requests, it shall first be indemnified to its satisfaction by
the Lenders against any and all liability and expense which may be incurred by it by reason of
taking or continuing to take any such action. Agent shall in all cases be fully protected in
acting, or in refraining from acting, under this Agreement or any other Loan Document in accordance
with a request or consent of all Lenders and such request and any action taken or failure to act
pursuant thereto shall be binding upon all the Lenders.
13.5 Notice of Default. Agent shall not be deemed to have knowledge or notice of the
occurrence of any default and/or Event of Default, unless Agent shall have received written notice
from a Lender or Borrower, describing such default or Event of Default. Agent will notify the
Lenders of its receipt of any such notice. Agent shall take such action with respect to an Event of
Default as may be directed in writing by the Required Lenders in accordance with Article 9(a);
provided, however, that while an Event of Default has occurred and is continuing, Agent may (but
shall not be obligated to) take such action, or refrain from taking such action, with respect to
such Event of Default as Agent shall deem advisable or in the best interest of the Lenders,
including without limitation, satisfaction of other security interests, liens or encumbrances on
the Collateral not permitted under the Loan Documents, payment of taxes on behalf of Borrower,
payments to landlords, warehouseman, bailees and other persons in possession of the Collateral and
other actions to protect and safeguard the Collateral, and actions with respect to insurance claims
for casualty events affecting Borrower and/or the Collateral.
13.6 Credit Decision; Disclosure of Information by Agent. Each Lender acknowledges
that no Agent-Related Person has made any representation or warranty to it, and that no act by
Agent hereafter taken, including any consent to and acceptance of any assignment or review of the
affairs of Borrower or any Affiliate thereof, shall be deemed to constitute any representation or
warranty by any Agent-Related Person to any Lender as to any matter, including whether
Agent-Related Persons have disclosed material information in their possession. Each Lender
represents to Agent that it has, independently and without reliance upon any Agent-Related Person
and based on such documents and information as it has deemed appropriate, made its own appraisal
of, and investigation into, the business, prospects, operations, property, financial and other
condition and creditworthiness of Borrower and its respective Subsidiaries, and all applicable bank
or other regulatory Laws relating to the transactions contemplated hereby, and made its own
decision to enter into this Agreement and to extend credit to Borrower hereunder. Each Lender also
represents that it will, independently and without reliance upon any Agent-Related Person and based
on such documents and information as it shall deem appropriate at the time, continue to make its
own credit analysis, appraisals and decisions in taking or not taking action under this Agreement
and the other Loan Documents, and to make such investigations as it deems necessary to inform
itself as to the business, prospects, operations, property, financial and other condition and
creditworthiness of Borrower. Except for notices, reports and other documents expressly required to
be furnished to the Lenders by Agent herein, Agent shall not have any duty or responsibility to
provide any Lender with any credit or other information concerning the business, prospects,
operations, property, financial and other condition or creditworthiness of Borrower or any of its
Affiliates which may come into the possession of any Agent-Related Person.
13.7 Indemnification of Agent. Whether or not the transactions contemplated hereby are
consummated, each Lender shall, severally and pro rata based on its respective Pro Rata Share,
indemnify upon demand each Agent-Related Person (to the extent not reimbursed by or on behalf of
Borrower and without limiting the obligation of Borrower to do so), and hold harmless each
Agent-Related Person from and against any and all Indemnified Liabilities (which shall not include
legal expenses of Agent incurred in connection with the closing of the transactions contemplated by
this Agreement) incurred by it; provided, however, that no Lender shall be liable for the payment
to any Agent-Related Person of any portion of such Indemnified Liabilities to the extent determined
in a judgment by a court of competent jurisdiction to have resulted from such Agent-Related
Person’s own gross negligence or willful misconduct; provided, however, that no action taken in
accordance with the directions of the Required Lenders shall be deemed to constitute gross
negligence or willful misconduct for purposes of this Section 13.7. Without limitation of the
foregoing, each Lender shall, severally and pro rata based on its respective Pro Rata Share,
reimburse Agent upon demand for its ratable share of any costs or out-of-pocket expenses (including
Lenders’ Expenses incurred after the closing of the transactions contemplated by this Agreement)
incurred by Agent (in its capacity as Agent, and not as a Lender) in connection with the
preparation, execution, delivery, administration, modification, amendment or enforcement (whether
through negotiations, legal proceedings or otherwise) of, or legal advice in respect of rights or
responsibilities under, this Agreement, any other Loan Document, or any document contemplated
by or referred to herein, to the extent that Agent is not reimbursed for such expenses by or on
behalf of Borrower. The undertaking in this Section 13.7 shall survive the payment in full of the
Obligations, the termination of this Agreement and the resignation of Agent.
25
13.8 Agent in its Individual Capacity. With respect to its Credit Extensions, MidCap
shall have the same rights and powers under this Agreement as any other Lender and may exercise
such rights and powers as though it were not Agent, and the terms “Lender” and “Lenders” include
MidCap in its individual capacity.
13.9 Successor Agent. Agent may resign as Agent upon ten (10) days’ notice to the
Lenders. If Agent resigns under this Agreement, all Lenders shall appoint from among the Lenders
(or the affiliates thereof) a successor Agent for the Lenders, which successor Agent shall (unless
an Event of Default has occurred and is continuing) be subject to the approval of Borrower (which
approval shall not be unreasonably withheld or delayed). If no successor Agent is appointed prior
to the effective date of the resignation of Agent, Agent may appoint, after consulting with the
Lenders, a successor Agent from among the Lenders (or the affiliates thereof). Upon the acceptance
of its appointment as successor Agent hereunder, the Person acting as such successor Agent shall
succeed to all the rights, powers and duties of the retiring Agent and the respective term “Agent”
means such successor Agent and the retiring Agent’s appointment, powers and duties in such
capacities shall be terminated without any other further act or deed on its behalf. After any
retiring Agent’s resignation hereunder as Agent, the provisions of this Article 13 and Sections
2.4(d) and 12.2 shall inure to its benefit as to any actions taken or omitted to be taken by it
while it was Agent under this Agreement. If no successor Agent has accepted appointment as Agent by
the date ten (10) days following a retiring Agent’s notice of resignation, the retiring Agent’s
resignation shall nevertheless thereupon become effective and the Lenders shall perform all of the
duties of Agent hereunder until such time, if any, as the Lenders appoint a successor agent as
provided for above.
13.10 Agent May File Proofs of Claim. In case of the pendency of any receivership,
insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other
judicial proceeding relative to Borrower, Agent (irrespective of whether the principal of any Loan,
shall then be due and payable as herein expressed or by declaration or otherwise and irrespective
of whether Agent shall have made any demand on Borrower) shall be entitled and empowered, by
intervention in such proceeding or otherwise:
(a) to file and prove a claim for the whole amount of the principal and interest owing and
unpaid in respect of the Credit Extensions and all other Obligations that are owing and unpaid and
to file such other documents as may be necessary or advisable in order to have the claims of the
Lenders and Agent (including any claim for the reasonable compensation, expenses, disbursements and
advances of the Lenders and Agent and their respective agents and counsel and all other amounts due
the Lenders and Agent allowed in such judicial proceeding); and
(b) to collect and receive any monies or other property payable or deliverable on any such
claims and to distribute the same;
and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official
in any such judicial proceeding is hereby authorized by each Lender to make such payments to Agent
and, in the event that Agent shall consent to the making of such payments directly to the Lenders,
to pay to Agent any amount due for the reasonable compensation, expenses, disbursements and
advances of Agent and its agents and counsel, and any other amounts due Agent under Section 2.4(d).
To the extent that Agent fails timely to do so, each Lender may file a claim relating to such
Lender’s claim.
13.11 Collateral and Guaranty Matters. The Lenders irrevocably authorize Agent, at its
option and in its discretion, to release any Guarantor and any Lien on any Collateral granted to or
held by Agent under any Loan Document (i) upon the date that all Obligations due hereunder have
been fully and indefeasibly paid in full and no Term Loan Commitments or other obligations of any
Lender to provide funds to Borrower under this Agreement remain outstanding, (ii) that is
transferred or to be transferred as part of or in connection with any Transfer permitted hereunder
or under any other Loan Document, or (iii) as approved in accordance with Section 12.11. Upon
request by Agent at any time, all Lenders will confirm in writing Agent’s authority to release its
interest in particular types or items of Property, pursuant to this Section 13.11.
26
13.12 Cooperation of Borrower. If necessary, Borrower agrees to (i) execute any
documents (including new Secured Promissory Notes) reasonably required to effectuate and
acknowledge each assignment of a Term Loan Commitment or Loan to an assignee in accordance with
Section 12.1, (ii) make Borrower’s management available to meet with Agent and prospective
participants and assignees of Term Loan Commitments or Credit Extensions and (iii) assist Agent or
the Lenders in the preparation of information relating to the financial affairs of Borrower as any
prospective participant or assignee of a Term Loan Commitment or Term Loan reasonably may request.
Subject to the provisions of Section 12.9 Borrower authorizes each Lender to disclose to any
prospective participant or assignee of a Term Loan Commitment, any and all information in such
Lender’s possession concerning Borrower and its financial affairs which has been delivered to such
Lender by or on behalf of Borrower pursuant to this Agreement, or which has been delivered to such
Lender by or on behalf of Borrower in connection with such Lender’s credit evaluation of Borrower
prior to entering into this Agreement.
14 DEFINITIONS
14.1 Definitions. As used in this Agreement, the following terms have the following
meanings:
“Account” is any “account” as defined in the Code with such additions to such term as may
hereafter be made, and includes, without limitation, all accounts receivable and other sums owing
to Borrower.
“Account Debtor” is any “account debtor” as defined in the Code with such additions to such
term as may hereafter be made.
“Advance” means an advance or disbursement of proceeds to or for the account of Borrower in
respect of a Term Loan.
“Affiliate” of any Person is a Person that owns or controls directly or indirectly the Person,
any Person that controls or is controlled by or is under common control with the Person, and each
of that Person’s senior executive officers, directors, partners and, for any Person that is a
limited liability company, that Person’s managers and members.
“Agent” means, MidCap, not in its individual capacity, but solely in its capacity as agent on
behalf of and for the benefit of the Lenders.
“Agent-Related Person” means Agent, together with its Affiliates, and the officers, directors,
employees, agents, advisors, auditors and attorneys-in-fact of such Persons; provided, however,
that no Agent-Related Person shall be an Affiliate of Borrower.
“Agreement” is defined in the preamble hereof.
“Amortization Date” is December 1, 2010.
“Anti-Terrorism Laws” means any Laws relating to terrorism or money laundering, including
Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the Laws comprising
or implementing the Bank Secrecy Act, and the Laws administered by OFAC.
“Approved Fund” means any (i) investment company, fund, trust, securitization vehicle or
conduit that is (or will be) engaged in making, purchasing, holding or otherwise investing in
commercial loans and similar extensions of credit in the ordinary course of its business or
(ii) any Person (other than a natural person) which temporarily warehouses loans for any Lender or
any entity described in the preceding clause (i) and that, with respect to each of the preceding
clauses (i) and (ii), is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or
(c) a Person (other than a natural person) or an Affiliate of a Person (other than a natural
person) that administers or manages a Lender.
“Approved Lender” has the meaning given it in Section 12.1.
“Assignment Agreement” means an agreement substantially in the form of Exhibit E hereto.
27
“Base LIBOR Rate” means, for any Interest Period, the rate per annum, determined by Agent in
accordance with its customary procedures, and utilizing such electronic or other quotation sources
as it considers appropriate (rounded upwards, if necessary, to the next 1/100%), to be the rate at
which Dollar deposits (for delivery on the first day of such Interest Period or, if such day is not
a Business Day, on the preceding Business Day) in the amount of One Million Dollars ($1,000,000)
are offered to major banks in the London interbank market on or about 11:00 a.m. (New York time)
two (2) Business Days prior to the commencement of such Interest Period, for a term comparable to
such Interest Period, which determination shall be conclusive in the absence of manifest error.
“Blocked Person” means any Person: (a) listed in the annex to, or is otherwise subject to the
provisions of, Executive Order No. 13224, (b) a Person owned or controlled by, or acting for or on
behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of,
Executive Order No. 13224, (c) a Person with which any Lender is prohibited from dealing or
otherwise engaging in any transaction by any Anti-Terrorism Law, (d) a Person that commits,
threatens or conspires to commit or supports “terrorism” as defined in Executive Order No. 13224,
or (e) a Person that is named a “specially designated national” or “blocked person” on the most
current list published by OFAC or other similar list.
“Borrower” is defined in the preamble hereof.
“Borrower’s Books” are all Borrower’s books and records including ledgers, federal and state
tax returns, records regarding Borrower’s assets or liabilities, the Collateral, business
operations or financial condition, and all computer programs or storage or any equipment containing
such information.
“Borrowing Resolutions” are, with respect to any Person, those resolutions adopted by such
Person’s Board of Directors and delivered by such Person to Agent approving the Loan Documents to
which such Person is a party and the transactions contemplated thereby, together with a certificate
executed by its secretary on behalf of such Person certifying that (a) such Person has the
authority to execute, deliver, and perform its obligations under each of the Loan Documents to
which it is a party, (b) that attached as Exhibit A to such certificate is a true, correct, and
complete copy of the resolutions then in full force and effect authorizing and ratifying the
execution, delivery, and performance by such Person of the Loan Documents to which it is a party,
(c) the name(s) of the Person(s) authorized to execute the Loan Documents on behalf of such Person,
together with a sample of the true signature(s) of such Person(s), and (d) that Agent and the
Lenders may conclusively rely on such certificate unless and until such Person shall have delivered
to Agent a further certificate canceling or amending such prior certificate.
“Business Day” is any day that is not a Saturday, Sunday or a day on which Agent is closed.
“Cash Equivalents” are (a) marketable direct obligations issued or unconditionally guaranteed
by the United States or any agency or any State thereof having maturities of not more than one (1)
year from the date of acquisition; (b) commercial paper maturing no more than one (1) year after
its creation and having the highest rating from either Standard & Poor’s Ratings Group or Xxxxx’x
Investors Service, Inc., (c) certificates of deposit issued maturing no more than one (1) year
after issue, and (d) money market funds at least ninety-five percent (95%) of the assets of which
constitute Cash Equivalents of the kinds described in clauses (a) through (b) of this definition..
For the avoidance of doubt, the direct purchase by Borrower, co-borrower, or any subsidiary of
Borrower of any Auction Rate Securities, or purchasing participations in, or entering into any type
of swap or other derivative transaction, or otherwise holding or engaging in any ownership interest
in any type of Auction Rate Security by Borrower, co-borrower, or any subsidiary of Borrower shall
be conclusively determined by the Lenders as an ineligible Cash Equivalent, and any such
transaction shall expressly violate each other provision of this agreement governing Permitted
Investments. Notwithstanding the foregoing, Cash Equivalents does not include and each Borrower
and Subsidiary is prohibited from purchasing, purchasing participations in, entering into any type
of swap or other equivalent derivative transaction, or otherwise holding or engaging in any
ownership interest in any type of debt instrument, including, without limitation, any corporate or
municipal bonds with a long-term nominal maturity for which the interest rate is reset through a
dutch auction and more commonly referred to as an auction rate security.
“Change in Control” means any event, transaction, or occurrence as a result of which (a) any
“person” (as such term is defined in Sections 3(a)(9) and 13(d)(3) of the Exchange Act), other than
a trustee or other fiduciary holding securities under an employee benefit plan of Borrower, is or
becomes a beneficial owner (within the meaning Rule 13d-3 promulgated under the Exchange Act),
directly or indirectly, of securities of Borrower, representing twenty-five percent (25%) or more
of the combined voting power of Borrower’s then outstanding securities; or (b) during any period of
twelve consecutive calendar months, individuals who at the beginning of such period constituted the
Board of Directors of Borrower
(together with any new directors whose election by the Board of Directors of Borrower was
approved by a vote of not less than two-thirds of the directors then still in office who either
were directions at the beginning of such period or whose election or nomination for election was
previously so approved) cease for any reason other than death or disability to constitute a
majority of the directors then in office.
28
“Claims” are defined in Section 12.2.
“Code” is the Uniform Commercial Code, as the same may, from time to time, be enacted and in
effect in the State of Maryland; provided, that, to the extent that the Code is used to define any
term herein or in any Loan Document and such term is defined differently in different Articles or
Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern;
provided further, that in the event that, by reason of mandatory provisions of Law, any or all of
the attachment, perfection, or priority of, or remedies with respect to, Agent’s Lien on any
Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the
State of Maryland, the term “Code” shall mean the Uniform Commercial Code as enacted and in effect
in such other jurisdiction solely for purposes of the provisions thereof relating to such
attachment, perfection, priority, or remedies and for purposes of definitions relating to such
provisions.
“Collateral” is any and all properties, rights and assets of Borrower described on Exhibit
A.
“Collateral Account” is any Deposit Account, Securities Account, or Commodity Account.
“Commitment Percentage” is set forth in Schedule 1.1, as amended from time to time.
“Commodity Account” is any “commodity account” as defined in the Code with such additions to
such term as may hereafter be made.
“Communication” is defined in Section 10.
“Compliance Certificate” is that certain certificate in the form attached hereto as
Exhibit C.
“Contingent Obligation” is, for any Person, any direct or indirect liability, contingent or
not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation
of another such as an obligation directly or indirectly guaranteed, endorsed, co-made, discounted
or sold with recourse by that Person, or for which that Person is directly or indirectly liable;
(b) any obligations for undrawn letters of credit for the account of that Person; and (c) all
obligations from any interest rate, currency or commodity swap agreement, interest rate cap or
collar agreement, or other agreement or arrangement designated to protect a Person against
fluctuation in interest rates, currency exchange rates or commodity prices; but “Contingent
Obligation” does not include endorsements in the ordinary course of business. The amount of a
Contingent Obligation is the stated or determined amount of the primary obligation for which the
Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability
for it determined by the Person in good faith; but the amount may not exceed the maximum of the
obligations under any guarantee or other support arrangement.
“Control Agreement” is any control agreement entered into among the depository institution at
which Borrower maintains a Deposit Account or the securities intermediary or commodity intermediary
at which Borrower maintains a Securities Account or a Commodity Account, Borrower, and Agent
pursuant to which Agent obtains control (within the meaning of the Code) for the benefit of the
Lenders over such Deposit Account, Securities Account, or Commodity Account.
“Credit Extension” is any Term Loan or any other extension of credit by Agent or the Lenders
for Borrower’s benefit.
“DEA” means the Drug Enforcement Administration of the United States of America and any
successor agency thereof.
“Default” is any event which with notice or passage of time or both, would constitute an Event
of Default.
“Default Rate” is defined in Section 2.3(c).
29
“Deposit Account” is any “deposit account” as defined in the Code with such additions to such
term as may hereafter be made.
“Designated Deposit Account” is the deposit account maintained by Borrower with SVB and
designated as the “Designated Deposit Account” and over which Agent shall be granted control for
the ratable benefit of all Lenders.
“Dollars,” “dollars” and “$” each mean lawful money of the United States.
“Drug Application” means a new drug application, an abbreviated drug application, or a product
license application for any Product, as appropriate, as those terms are defined in the FDCA.
“EBITDA” shall mean with respect to Borrower and its Subsidiaries on a consolidated basis (a)
Net Income, plus (b) Interest Expense, plus (c) to the extent deducted in the calculation of Net
Income, depreciation expense and amortization expense, plus (d) non-cash stack compensation
expense, plus (e) income tax expense.
“Effective Date” is defined in the preamble of this Agreement.
“Eligible Assignee” means (i) a Lender, (ii) an Affiliate of a Lender, (iii) an Approved Fund
and (iv) any commercial bank, savings and loan association or savings bank or any other entity
which is an “accredited investor” (as defined in Regulation D under the Securities Act of 1933, as
amended) and which extends credit or buys loans as one of its businesses, including insurance
companies, mutual funds, lease financing companies and commercial finance companies, in each case,
which either (A) has a rating of BBB or higher from Standard & Poor’s Rating Group and a rating of
Baa2 or higher from Xxxxx’x Investors Service, Inc. at the date that it becomes a Lender or (B) has
total assets in excess of $5,000,000,000, and in each case of clauses (i) through (iv), which,
through its applicable lending office, is capable of lending to Borrower without the imposition of
any withholding or similar taxes; provided that notwithstanding the foregoing, “Eligible Assignee”
shall not include Borrower, any Guarantor or any of Borrower’s or any Guarantor’s Affiliates or
Subsidiaries. Notwithstanding the foregoing, in connection with assignments by a Lender due to a
forced divestiture at the request of any regulatory agency, the restrictions set forth herein shall
not apply and Eligible Assignee shall mean any Person or party.
“Equipment” is all “equipment” as defined in the Code with such additions to such term as may
hereafter be made, and includes without limitation all machinery, fixtures, goods, vehicles
(including motor vehicles and trailers), and any interest in any of the foregoing.
“Equity Event” shall mean the receipt by Borrower, after the Effective Date and prior to
August 31, 2010, of unrestricted net cash proceeds of at least Five Million Dollars ($5,000,000.00)
from the closing of the issuance and sale of Borrower’s equity securities.
“ERISA” is the Employee Retirement Income Security Act of 1974, and its regulations.
“Event of Default” is defined in Section 8.
“FDA” means the Food and Drug Administration of the United States of America or any successor
entity thereto.
“FDCA” means the Federal Food, Drug and Cosmetic Act, as amended, 21 U.S.C. Section 301 et
seq. and all regulations promulgated thereunder.
“Final Payment” is a payment (in addition to and not a substitution for the regular monthly
payments of principal plus accrued interest) due on the earlier to occur of (a) the Maturity Date,
or (b) the acceleration of any Term Loan, or (c) the prepayment of a Term Loan pursuant to Section
2.2(c) or (d), equal to the original Term Loan Commitments multiplied by the Final Payment
Percentage.
“Final Payment Percentage” is three percent (3.00%).
30
“Foreign Subsidiary” shall mean each of the following Subsidiaries of Biolase: (i) Biolase
Europe, GmbH, a company organized under the laws of Germany, (ii) Biolase Spain, S.L., a company
organized under the laws of Spain, (iii) Biolase Australia Pty. Ltd., a company organized under the
laws of Australia, and (iv) Biolase (NZ) Limited, a company organized under the laws of New
Zealand.
“Funding Date” is any date on which a Credit Extension is made to or on account of Borrower
which shall be a Business Day.
“GAAP” is generally accepted accounting principles set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public
Accountants and statements and pronouncements of the Financial Accounting Standards Board or in
such other statements by such other Person as may be approved by a significant segment of the
accounting profession in the United States, which are applicable to the circumstances as of the
date of determination.
“General Intangibles” is all “general intangibles” as defined in the Code in effect on the
date hereof with such additions to such term as may hereafter be made, and includes without
limitation, all copyright rights, copyright applications, copyright registrations and like
protections in each work of authorship and derivative work, whether published or unpublished, any
patents, trademarks, service marks and, to the extent permitted under applicable Law, any
applications therefor, whether registered or not, any trade secret rights, including any rights to
unpatented inventions, payment intangibles, royalties, contract rights, goodwill, franchise
agreements, purchase orders, customer lists, route lists, telephone numbers, domain names, claims,
income and other tax refunds, security and other deposits, options to purchase or sell real or
personal property, rights in all litigation presently or hereafter pending (whether in contract,
tort or otherwise), insurance policies (including without limitation key man, property damage, and
business interruption insurance), payments of insurance and rights to payment of any kind.
“Governmental Approval” is any consent, authorization, approval, order, license, franchise,
permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or
other act by or in respect of, any Governmental Authority.
“Governmental Authority” is any nation or government, any state or other political subdivision
thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other
entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions
of or pertaining to government, any securities exchange and any self-regulatory organization.
“Guarantor” is, individually and collectively, jointly and severally, BL Acquisition Corp., a
Delaware corporation (“BL Acquisition”)and BL Acquisition II, Inc., a Delaware corporation (“BL
Acquisition II”), and any present or future guarantor of the Obligations.
“Guarantor Security Agreement” is the Security Agreement dated as of the Effective Date made
by BL Acquisition and BL Acquisition II in favor of the Agent and the Lenders.
“Indebtedness” is (a) indebtedness for borrowed money or the deferred price of property or
services, such as reimbursement and other obligations for surety bonds and letters of credit, (b)
obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease
obligations, and (d) Contingent Obligations.
“Indemnified Liabilities” is defined in Section 12.2.
“Indemnified Person” is defined in Section 12.2.
“Insolvency Proceeding” is any proceeding by or against any Person under the United States
Bankruptcy Code, or any other bankruptcy or insolvency Law, including assignments for the benefit
of creditors, compositions, extensions generally with its creditors, or proceedings seeking
reorganization, arrangement, or other relief.
31
“Intellectual Property” includes without limitation, all copyright rights, copyright
applications, copyright registrations and like protections in each work of authorship and
derivative work, whether published or unpublished, any
patents, patent applications and like protections, including improvements, divisions,
continuations, renewals, reissues, extensions, and continuations-in-part of the same, trademarks,
trade names, service marks, mask works, rights of use of any name, domain names, or any other
similar rights, any applications therefor, whether registered or not, and the goodwill of the
business of Borrower connected with and symbolized thereby, know-how, operating manuals, trade
secret rights, clinical and non-clinical data, rights to unpatented inventions, and any claims for
damage by way of any past, present, or future infringement of any of the foregoing.
“Interest Expense” means for any fiscal period with respect to Borrower and its Subsidiaries
on a consolidated basis, interest expense (whether cash or non-cash) determined in accordance with
GAAP for the relevant period ending on such date, including, in any event, interest expense with
respect to any Credit Extension and other Indebtedness of Borrower and its Subsidiaries, including,
without limitation or duplication, all commissions, discounts, or related amortization and other
fees and charges with respect to letters of credit and bankers’ acceptance financing and the net
costs associated with interest rate swap, cap, and similar arrangements, and the interest portion
of any deferred payment obligation (including leases of all types).
“Interest Period” means the one-month period starting on the first (1st) day of
each month and ending on the last day of such month; provided, however, that the first
(1st) Interest Period for each Advance shall commence on the date that the applicable
Advance is made and end on the last day of such month.
“Interest Rate Determination Date” means the second (2nd) Business Day prior to the
first (1st) day of the related Interest Period.
“Inventory” is all “inventory” as defined in the Code in effect on the date hereof with such
additions to such term as may hereafter be made, and includes without limitation all merchandise,
raw materials, parts, supplies, packing and shipping materials, work in process and finished
products, including without limitation such inventory as is temporarily out of Borrower’s custody
or possession or in transit and including any returned goods and any documents of title
representing any of the above.
“Investment” is any beneficial ownership interest in any Person (including stock, partnership
interest or other securities), and any loan, advance or capital contribution to any Person.
“IP Agreement” is that certain Intellectual Property Security Agreement executed and delivered
by Borrower to Agent dated of even date herewith.
“Laws” means any and all federal, state, provincial, territorial, local and foreign statutes,
laws, judicial decisions, regulations, guidances, guidelines, ordinances, rules, judgments, orders,
decrees, codes, plans, injunctions, permits, concessions, grants, franchises, governmental
agreements and governmental restrictions, whether now or hereafter in effect, which are applicable
to any Borrower in any particular circumstance.
“Lender” is any one of the Lenders.
“Lenders” shall mean the Persons identified on Schedule 1.1 hereto and each assignee that
becomes a party to this Agreement pursuant to Section 12.1.
“Lenders’ Expenses” are all audit fees and expenses, costs, and expenses (including reasonable
attorneys’ fees and expenses) of Lenders and Agent for preparing, amending, negotiating,
administering, defending and enforcing the Loan Documents (including, without limitation, those
incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred by Agent or
the Lenders in connection with the Loan Documents.
“LIBOR Rate” means for each Interest Period, the rate per annum determined by Agent (rounded
upwards, if necessary, to the next 1/100th%) by dividing (a) the Base LIBOR Rate for such Interest
Period, by (b) 100% minus the Reserve Percentage. The LIBOR Rate shall be adjusted on and as of
the effective day of any change in the Reserve Percentage.
32
“LIBOR Rate Margin” is nine and one quarter percent (9.25%) per annum; provided, however, that
in the event that Borrower fails to satisfy the Post-Closing Covenant, the LIBOR Rate Margin shall
be eleven and one quarter percent (11.25%) per annum, effective as of the thirtieth day after the
Effective Date and thereafter.
“Lien” is a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other
encumbrance of any kind, whether voluntarily incurred or arising by operation of Law or otherwise
against any property.
“Loan Documents” are, collectively, this Agreement, the Warrant, the Perfection Certificate,
the IP Agreement, the Unconditional Guaranty, the Guaranty Security Agreement, any note, or notes
or guaranties executed by Borrower in connection with the indebtedness governed by this Agreement,
and any other present or future agreement between Borrower and/or for the benefit of the Lenders
and Agent in connection with this Agreement, all as amended, restated, or otherwise modified.
“Material Adverse Change” is (a) a material impairment in the perfection or priority of
Agent’s Lien in the Collateral or in the value of such Collateral; (b) a material adverse change in
the business, operations, or condition (financial or otherwise) or prospects of Borrower; or (c) a
material impairment of the prospect of repayment of any portion of the Obligations.
“Material Intellectual Property” is all of Borrower’s Intellectual Property that is material
to the condition (financial or other), business or operations of Borrower.
“Maturity Date” is May 1, 2013.
“Net Income” means, as calculated on a consolidated basis for Borrower and its Subsidiaries
for any period as at any date of determination, the net profit (or loss), after provision for
taxes, of Borrower and its Subsidiaries for such period taken as a single accounting period.
“Obligations” are all of Borrower’s obligations to pay when due any debts, principal,
interest, Lenders’ Expenses, the Prepayment Fee, the Final Payment, and other amounts Borrower owes
the Lenders now or later, under this Agreement or the other Loan Documents, including, without
limitation, interest accruing after Insolvency Proceedings begin (whether or not allowed) and
debts, liabilities, or obligations of Borrower assigned to the Lenders and/or Agent, and the
performance of Borrower’s duties under the Loan Documents.
“OFAC” is the U.S. Department of Treasury Office of Foreign Assets Control.
“OFAC Lists” are, collectively, the Specially Designated Nationals and Blocked Persons List
maintained by OFAC pursuant to Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001)
and/or any other list of terrorists or other restricted Persons maintained pursuant to any of the
rules and regulations of OFAC or pursuant to any other applicable Executive Orders.
“Operating Documents” are, for any Person, such Person’s formation documents, as certified
with the Secretary of State of such Person’s state of formation on a date that is no earlier than
30 days prior to the Effective Date, and (a) if such Person is a corporation, its bylaws in current
form, (b) if such Person is a limited liability company, its limited liability company agreement
(or similar agreement), and (c) if such Person is a partnership, its partnership agreement (or
similar agreement), each of the foregoing with all current amendments or modifications thereto.
“Payment/Advance Form” is that certain form attached hereto as Exhibit B.
“Payment Date” is the first calendar day of each calendar month.
“Perfection Certificate” is defined in Section 5.1.
33
“Permits” means licenses, certificates, accreditations, product clearances or approvals,
provider numbers or provider authorizations, marketing authorizations, other authorizations,
registrations, permits, consents and approvals required in connection with the conduct of
Borrower’s or any Subsidiary’s business or to comply with any applicable Laws,
including, without limitation, drug listings and drug establishment registrations under 21
U.S.C. Section 510, registrations issued by DEA under 21 U.S.C. Section 823 (if applicable to any
Product), and those issued by State governments for the conduct of Borrower’s or any Subsidiary’s
business.
“Permitted Indebtedness” is:
(a) Borrower’s Indebtedness to the Lenders and Agent under this Agreement and the other Loan
Documents;
(b) Indebtedness existing on the Effective Date and shown on the Perfection Certificate;
(c) Subordinated Debt;
(d) unsecured Indebtedness to trade creditors incurred in the ordinary course of business;
(e) Indebtedness secured by Permitted Liens; and
(h) extensions, refinancings, modifications, amendments and restatements of any items of
Permitted Indebtedness (a) through (e) above, provided that the principal amount thereof is not
increased or the terms thereof are not modified to impose more burdensome terms upon Borrower or
its Subsidiary, as the case may be.
“Permitted Investments” are:
(a) Investments shown on the Perfection Certificate and existing on the Effective Date;
provided, however that on and after the Effective Date Borrower’s Investments in
the Foreign Subsidiaries shall be limited to amounts necessary to fund the operations of the
Foreign Subsidiaries in the ordinary course, which amounts shall not exceed $125,000 in the
aggregate in any fiscal year for all Foreign Subsidiaries; and
(b) Investments consisting of Cash Equivalents.
“Permitted Liens” are:
(a) Liens existing on the Effective Date and shown on the Perfection Certificate or arising
under this Agreement and the other Loan Documents;
(b) Liens for taxes, fees, assessments or other government charges or levies, either not
delinquent or being contested in good faith and for which Borrower maintains adequate reserves on
its Books, provided that no notice of any such Lien has been filed or recorded under the Internal
Revenue Code of 1986, as amended , and the Treasury Regulations adopted thereunder;
(c) purchase money Liens (i) on Equipment acquired or held by Borrower incurred for financing
the acquisition of the Equipment securing no more than One Hundred Thousand Dollars ($100,000) in
the aggregate amount outstanding, or (ii) existing on Equipment when acquired, if the Lien
is confined to the property and improvements and the proceeds of the Equipment; and
(d) Liens incurred in the extension, renewal or refinancing of the indebtedness secured by
Liens described in (a) and (c) above, but any extension, renewal or replacement Lien must
be limited to the property encumbered by the existing Lien and the principal amount of the
Indebtedness may not increase.
“Person” is any individual, sole proprietorship, partnership, limited liability company, joint
venture, company, trust, unincorporated organization, association, corporation, institution, public
benefit corporation, firm, joint stock company, estate, entity or government agency.
34
“Prepayment Fee” means with respect to any Term Loan subject to prepayment prior to the
Maturity Date, whether by mandatory or voluntary prepayment, acceleration or otherwise, an
additional fee payable to the Lenders in amount equal to:
(i) for a prepayment made on or after the Effective Date through and including the date which
is twelve (12) months after the Effective Date, six percent (6.00%) of the outstanding principal
amount of the Term Loans;
(ii) for a prepayment made after the date which is twelve (12) months after the Effective Date
through and including the date which is twenty-four (24) months after the Effective Date, four
percent (4.00%) of the outstanding principal amount of the Term Loans; and
(ii) for a prepayment made after the date which is twenty-four (24) months after the Effective
Date and prior to the Maturity Date, two percent (2.00%) of the outstanding principal amount of the
Term Loans.
“Pro Rata Share” means, with respect to each Lender, a percentage (expressed as a decimal,
rounded to the ninth decimal place) determined by dividing the amount of Term Loans held by such
Lender by the aggregate amount of all outstanding Term Loans.
“Products” means any products manufactured, sold, developed, tested or marketed by any
Borrower or any of its Subsidiaries, including without limitation, those products set forth on
Schedule 5.11 (as updated from time to time in accordance with Section 6.2(e) above); provided
that, if Borrower shall fail to comply with the obligations under Section 6.2(e) to give notice to
Agent and update Schedule 5.11 prior to manufacturing, selling, developing, testing or marketing
any new Product, any such improperly undisclosed Product shall be deemed to be included in this
definition; and provided, further, that products manufactured by Borrower for unaffiliated third
parties shall not be deemed “Products” hereunder.
“Registered Organization” is any “registered organization” as defined in the Code with such
additions to such term as may hereafter be made
“Required Lenders” means (i) for so long as all of the Persons that are Lenders on the
Effective Date (each an “Original Lender”) have not assigned or transferred any of their interests
in their respective Term Loans, Lenders holding one hundred percent (100%) of the aggregate
outstanding principal balance of the Term Loans, or (ii) at any time from and after any Original
Lender has assigned or transferred any interest in its Term Loans, Lenders holding sixty-six
percent (66%) or more of the aggregate outstanding principal balance of the Term Loans, plus, in
respect of this clause (ii), (A) each Original Lender that has not assigned or transferred any
portion of its respective Term Loans and (B) each assignee of an Original Lender provided such
assignee was assigned or transferred and continues to hold 100% of the assigning Original Lender’s
interest in the Term Loans (in each case in respect of clauses (A) and (B) of this clause (ii),
whether or not such Lender is included within the Lenders holding sixty-six percent (66%) of the
Terms Loans); provided, however, that notwithstanding the foregoing, for purposes of Section 9.1(b)
hereof, “Required Lenders” means (i) for so long as all Original Lenders retain 100% of their
interests in their respective Term Loans, Lenders holding one hundred percent (100%) of the
aggregate outstanding principal balance of the Term Loans, or (ii) at any time from and after any
Original Lender has assigned or transferred any interest in its Term Loans, Lenders holding
sixty-six percent (66%) or more of the aggregate outstanding principal balance of the Term Loans,
plus, in respect of this clause (ii), each Original Lender that has not assigned or transferred any
portion of its respective Term Loan (in each case in respect of this clause (ii), whether or not
such Original Lender is included within the Lenders holding sixty-six percent (66%) of the Term
Loans). For purposes of this definition only, a Lender shall be deemed to include itself, and any
Lender that is an Affiliate or Approved Fund of such Lender.
“Required Permit” means a Permit (a) issued or required under Laws applicable to the business
of Borrower or any of its Subsidiaries or necessary in the manufacturing, importing, exporting,
possession, ownership, warehousing, marketing, promoting, sale, labeling, furnishing, distribution
or delivery of goods or services under Laws applicable to the business of Borrower or any of its
Subsidiaries or any Drug Application (including without limitation, at any point in time, all
licenses, approvals and permits issued by the FDA or any other applicable Governmental Authority
necessary for the testing, manufacture, marketing or sale of any Product by any applicable
Borrower(s) as such activities are being conducted by such Borrower with respect to such Product at
such time), and (b) issued by any Person from which Borrower or any of their Subsidiaries have
received an accreditation.
“Requirement of Law” is as to any Person, the organizational or governing documents of such
Person, and any Law (statutory or common), treaty, rule or regulation or determination of an
arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon
such Person or any of its property or to which such Person or any of its property is subject.
35
“Reserve Percentage” means, on any day, for any Lender, the maximum percentage prescribed by
the Board of Governors of the Federal Reserve System (or any successor Governmental Authority) for
determining the reserve requirements (including any basic, supplemental, marginal, or emergency
reserves) that are in effect on such date with respect to eurocurrency funding (currently referred
to as “eurocurrency liabilities”) of that Lender, but so long as such Lender is not required or
directed under applicable regulations to maintain such reserves, the Reserve Percentage shall be
zero.
“Responsible Officer” is any of the President and Chief Executive Officer or Chief Financial
Officer of Borrower.
“Secured Promissory Note” is defined in Section 2.7.
“Secured Promissory Note Record” is a record maintained by each Lender with respect to the
outstanding Obligations and credits made thereto.
“Securities Account” is any “securities account” as defined in the Code with such additions to
such term as may hereafter be made.
“Subordinated Debt” is indebtedness incurred by Borrower subordinated to all of Borrower’s now
or hereafter indebtedness to the Lenders (pursuant to a subordination, intercreditor, or other
similar agreement in form and substance satisfactory to Agent and the Lenders entered into between
Agent, Borrower and the other creditor), on terms acceptable to Agent and the Lenders.
“Subsidiary” means, with respect to any Person, any Person of which more than 50.0% of the
voting stock or other equity interests (in the case of Persons other than corporations) is owned or
controlled, directly or indirectly, by such Person or one or more of Affiliates of such Person.
“Term Loan” or “Term Loans” is defined in Section 2.2(a) hereof.
“Term A Loan” is defined in Section 2.2(b) hereof.
“Term B Loan” is defined in Section 2.2(b) hereof.
“Term B Loan Draw Period” is the period commencing upon the occurrence of the Equity Event and
continuing through the earlier to occur of (i) August 31, 2010, and (ii) an Event of Default.
“Term Loan Commitment” means, for any Lender, the obligation of such Lender to make a Term
Loan, up to the principal amount shown on Schedule 1.1. “Term Loan Commitments” means the
aggregate amount of such commitments of all Lenders.
“Transfer” is defined in Section 7.1.
“Unconditional Guaranty” is the Unconditional Guaranty dated as of the Effective Date made by
BL Acquisition and BL Acquisition II in favor of the Agent and the Lenders.
“Warrants” are those certain Warrants to Purchase Stock dated as of the Effective Date
executed by Borrower in favor of each Lender or such Lender’s Affiliates.
36
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the
Effective Date.
BORROWER: | ||||||
BIOLASE TECHNOLOGY, INC. | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Name: | Xxxxx X. Xxxxxx | |||||
Title: | Chief Executive Officer | |||||
GUARANTORS: | ||||||
BL ACQUISITION CORP. | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Name: | Xxxxx X. Xxxxxx | |||||
Title: | Chief Executive Officer | |||||
BL ACQUISITION II, INC. | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Name: | Xxxxx X. Xxxxxx | |||||
Title: | Chief Executive Officer | |||||
AGENT: | ||||||
MIDCAP FINANCIAL, LLC, as Agent | ||||||
By: | /s/ Xxxx Xxxxxx | |||||
Name: | Xxxx Xxxxxx | |||||
Title: | Managing Director | |||||
LENDERS: | ||||||
MIDCAP FINANCIAL, LLC, as a Lender | ||||||
By: | /s/ Xxxx Xxxxxx | |||||
Name: | Xxxx Xxxxxx | |||||
Title: | Managing Director | |||||
SILICON VALLEY BANK, as a Lender | ||||||
By: | /s/ Xxxx Xxxxxxxxx | |||||
Name: | Xxxx Miklinksi | |||||
Title: | Vice President |
[Signature Page to the Loan and Security Agreement]
SCHEDULE 1.1
LENDERS AND COMMITMENTS
Lender | Term A Loan Commitment | Commitment Percentage | ||||||
MidCap Financial, LLC |
$ | 2,100,000 | 70 | % | ||||
Silicon Valley Bank |
$ | 900,000 | 30 | % | ||||
TOTAL TERM A LOANS |
$ | 3,000,000 | 100 | % |
Lender | Term B Loan Commitment | Commitment Percentage | ||||||
MidCap Financial, LLC |
$ | 1,400,000 | 70 | % | ||||
Silicon Valley Bank |
$ | 600,000 | 30 | % | ||||
TOTAL TERM B LOANS |
$ | 2,000,000 | 100 | % | ||||
TOTAL TERM LOANS |
$ | 5,000,000 | 100 | % |
[Signature Page to the Loan and Security Agreement]